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FOREWORD 
This dissertation describes the work performed under the supervision of Dr. Ana Coutinho 
at the Biological Fluorescence group from Centro de Química-Física Molecular 
(CQFM)/Instituto de Nanociência e Tecnologia (IN) at Instituo Superior Técnico (IST) in 
Lisbon, from September 2013 to September 2014. 
The studies presented here were targeted on elucidating the interaction mechanism of 
both salmon and human calcitonin polypeptides with anionic lipid membranes. This work 
was performed under the framework of the project “Modulation of calcitonin amyloid 
formation by lipid membranes and extracellular matrix: implications for the mechanism of 
cytotoxicity of amyloidogenic polypeptides” (Project PTDC/BBB-BQB/2661/2012) 
financed by Fundação para Ciência e Tecnologia (FCT) from Ministério da Educação e 
Ciência. Paulo Renato dos Santos Caldas was the recipient of a research fellowship. 
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ABSTRACT 
Recent studies have suggested that biological membranes can stimulate the pathological 
conversion of amyloidogenic proteins/peptides into toxic aggregates by providing a soft 
surface that can promote their misfolding and self-assembly. These interactions can be 
controlled by a range of biophysical features arising from the specific lipid composition of 
the membrane. In this work, both salmon and human calcitonins (sCT and hCT) were used 
as model polypeptides to study the role that negatively-charged lipid membranes can play 
in modulating their aggregation pathway. Specifically, a multi-parametric study based on 
steady-state and time-resolved fluorescence intensity and anisotropy measurements was 
carried out to study the interaction of both unlabelled and HiLyte Fluor 488-labelled sCT 
and hCT polypeptides (sCT-HL488 and hCT-HL488, respectively) with liposomes prepared 
with a variable anionic lipid content.  
The influence of a small set of solvents, namely several aliphatic and fluoro alcohols, on the 
photophysical properties of both the free HL488 dye and both HL488-labeled CT variants 
was first characterized. The changes in the fluorescence intensity decay kinetics displayed 
by the fluorescently-labelled peptides with the solvent used were assigned to an 
intramolecular photon-induced electron transfer mechanism dependent on the 
conformational dynamics of the polypeptide chain. In the second part of this work, the 
interaction of sCT-HL488 with lipid membranes was found to be critically dependent on 
the method used to prepare the samples (direct injection vs solvent evaporation). CT 
binding to liposomes was also established to be dominantly driven by electrostatic 
interactions. Furthermore, a coupled partition/oligomerization model was used to 
describe the biphasic fluorescence intensity data obtained when high sCT-HL488 
concentrations were used in the partition studies. The excitonic band detected in the 
absorption spectra of sCT-HL488 at a high P/L molar ratio (low phospholipid 
concentrations) revealed the formation of parallel (H-type) dimers between the HL488 
chromophores covalently linked to sCT, which were non-fluorescent. 
Keywords 
Salmon Calcitonin, Human Calcitonin, Hilyte Fluor 488, Fluorescence spectroscopy, 
Amyloid fibril formation, Lipid-protein-interaction, Membrane model system 
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RESUMO DO TRABALHO 
A acumulação in vivo de agregados proteicos insolúveis, genericamente designados por 
fibras amilóides, são o principal fenótipo de várias doenças graves categorizadas como 
patologias amilóides, onde se incluem a doença de Alzheimer, Parkinson e diabetes 
Mellitus tipo II. Estas doenças representam um problema de saúde alarmante a nível 
mundial pelo que há um interesse clínico urgente e significativo em compreender os 
factores que desencadeiam a formação destas estruturas para se poder desenvolver meios 
farmacológicos adequados que possam diminuir, ou atenuar, estas patologias. A maioria 
destas doenças são predominantemente esporádicas e resultam de problemas no folding 
de proteínas específicas que levam à sua agregação, e consequente formação de 
depósitos/placas, criando condições patológicas em determinados tecidos humanos. Deste 
modo, uma das chaves fundamentais para se perceber o desenvolvimento destas doenças 
reside no estudo dos mecanismos moleculares que levam ao misfolding e agregação destas 
proteínas in vitro. 
Estudos recentes mostraram que o estabelecimento de interacções lípido- 
péptido/proteína podem induzir um decréscimo na barreira de energia associada ao 
unfolding proteico, conduzindo à destabilização da estrutura nativa das 
proteínas/péptidos, e consequente misfolding. Com efeito, tem sido demonstrado que as 
membranas biológicas são capazes de promover a conversão de proteínas/péptidos em 
agregados tóxicos actuando como catalisadores do seu processo de fibrilhação, 
dependendo da composição lipídica da membrana (características estruturais dos seus 
lípidos componentes). No entanto, os mecanismos detalhados através dos quais a 
acumulação destes agregados compromete a integridade das membranas lipídicas ainda 
permanecem por esclarecer. 
Uma importante linha de investigação desenvolvida ao longo dos últimos anos no 
laboratório de acolhimento tem estado, precisamente, focada no estudo dos mecanismos 
que podem levar à formação de estruturas amilóides desencadeados pelo estabelecimento 
de interacções entre proteínas não amiloidogénicas e membranas carregadas 
negativamente, sob condições próximas das fisiológicas. O objectivo deste trabalho, que 
visou dar continuidade a este tópico, centrou-se no uso da calcitonina (CT) como 
polipéptido modelo para se estudar a capacidade das membranas lipídicas aniónicas em 
modularem a sua via de agregação em solução.  Neste estudo foram empregues ambas as 
variantes humana (hCT) e de salmão (sCT) desta hormona polipeptídica. 
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A CT é uma hormona com 32 resíduos de aminoácidos libertada pela glândula tiróide e 
que tem um papel importante no metabolismo do cálcio, sendo por isso administrada no 
tratamento da osteoporose e hipercalcemia. Nos últimos anos, a variante humana da 
calcitonina (hCT) tem sido cada vez menos utilizada neste tipo de tratamentos devido à 
sua tendência elevada em formar agregados que podem conduzir, eventualmente, à 
formação de depósitos de placas amilóides. Recentemente, a calcitonina de salmão (sCT) 
tem sido usada como uma alternativa clínica à hCT devido à sua maior potência 
farmacológica e menor tendência em sofrer agregação. Com efeito, a hCT é geralmente 
considerada um péptido amiloidogénico, o que a torna um modelo peptídico ideal para 
este tipo de estudo. Por outro lado, a sCT é útil devido ao facto de sua cinética de 
fibrilhação em solução ser muito mais lenta do que a da hCT permitindo, eventualmente, 
estudar em detalhe estados intermediários da cinética. 
Neste trabalho, os polipéptidos sCT e hCT foram utilizados quer na sua forma nativa (não 
derivatizada), quer conjugados com o fluoróforo HiLyte Fluor 488 (HL488) nos seus 
resíduos N-terminal (hCT-HL488 e sCT-HL488, respectivamente). A escolha desta posição 
de derivatização da CT visou minimizar a possibilidade de o fluoróforo conjugado 
interferir na formação de estruturas , já que é conhecido que esta envolve a sequência C-
terminal destes polipéptidos (resíduos 25-32). Deste modo, através da realização de 
medidas de fluorescência em estado estacionário e resolvidas no tempo, com o fim de 
caracterizar as propriedades de emissão de fluorescência intrínsecas e extrínsecas destes 
polipéptidos, procurou-se obter informação sobre (i) o seu estado de agregação em 
solução, e (ii) sobre o modo como a sua interacção com lipossomas era condicionada pela 
sua composição lipídica, nomeadamente pelo seu conteúdo em fosfolípidos aniónicos.  
Os estudos de partição foram realizados utilizando-se vesículas unilamelares grandes 
(LUVs) como sistema modelo de membranas, preparadas com uma composição lipídica 
variável, nomeadamente misturas de 1-palmitoil-2-oleoil-sn-glicero-3-fosfocolina (POPC), 
um fosfolípido zwitteriónico, com 0, 10, 20 ou 30 mol% de 1-palmitoil-2-oleoil-sn-glicero-
3-fosfoserina (POPS), um fosfolípido aniónico. Este tipo de vesiculas têm sido 
maioritariamente usadas para estudar interacções de péptidos com as membranas devido 
ao seu tamanho adequado (100 nm) e grau de curvatura, por comparação com outros 
sistemas vesiculares como, por exemplo, as vesículas unilamelares pequenas (SUVs) e 
gigantes (GUVs). 
 
Resumo 
 
9 
 
Numa primeira fase do trabalho, explorou-se a fluorescência intrínseca da sCT e hCT 
devida à presença  de um resíduo de  tirosina na estrutura primária de cada uma destas 
formas de calcitonina (Tyr22 e Tyr12, respectivamente). Foi realizada uma caracterização 
espectroscópica sumária das suas propriedades de emissão de fluorescência em solução 
tampão e efectuou-se ainda um estudo da sua partição para LUVs de POPC contendo 20 
mol% de POPS através da monitorização da sua anisotropia de fluorescência em estado 
estacionário. Após se ter minimizado experimentalmente o impacto da dispersão da 
radiação (scattering) causada pelas suspensões de lipossomas no valor deste parâmetro, 
recuperou-se um valor de 𝐾𝑝 = (5.5 ± 0.3)x10
5 para a sCT. Curiosamente, a variante 
humana, hCT, não mostrou qualquer tipo de interacção com os lipossomas preparados 
com uma composição lipídica idêntica, não havendo variações significativas em nenhum 
dos parâmetros espectroscópicos estudados com o aumento da concentração de 
fosfolípido no sistema.  
Este tipo de metodologia oferece a vantagem de não ser necessário usar fluoróforos 
extrínsecos ligados covalentemente à sequência peptídica, o que pode causar perturbações 
na estrutura nativa em solução. Contudo, a fluorescência intrínseca de ambas as variantes 
CT é pouco eficiente devido aos baixos coeficientes de absorção molar e rendimentos 
quânticos dos seus resíduos de Tyr, tornando a realização de medidas de fluorescência na 
presença de vesiculas lipídicas problemática uma vez que, aos comprimentos de onda 
usados, estas provocam um elevado nível de scatter no sistema. Por outro lado, as 
propriedades espectroscópicas deste fluoróforo intrínseco das proteínas são ainda 
caracteristicamente pouco sensíveis a pequenas alterações na polaridade do seu 
microambiente directo.  
Deste modo, o trabalho prosseguiu com o estudo das duas variantes de calcitonina 
derivatizadas, sCT-HL488 e hCT-HL488, respectivamente. Devido ao facto de a sonda 
fluorescente utilizada ter sido comercializada recentemente, não há muita informação 
disponível na literatura. A segunda fase do trabalho iniciou-se então com a realização de 
um estudo da variação das propriedades espectroscópicas da sonda livre HL488 e de 
ambas as variantes CT derivatizadas numa série de solventes para apurar o seu 
comportamento em meio homogéneo em função das propriedades do solvente. Neste 
estudo, foi usada uma variedade de álcoois com diferentes tamanhos de cadeia alifática 
(metanol, etanol, propanol, butanol) e fluoro álcoois (trifluoroetanol (TFE) e 
hexafluoroisopropanol (HFIP)), além de soluções tampão preparadas com força iónica 
variável.   
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Relativamente à sonda livre, os seus espectros de absorção e de emissão de fluorescência 
apresentaram um desvio batocromático progressivo com a diminuição da constante 
diéletrica dos álcoois alifáticos estudados. Contudo, na presença dos dois fluoro álcoois, 
ambos os espectros da sonda livre apresentaram um desvio hipsocromático significativo 
relativamente ao seu comportamento em solução aquosa, o que poderá ser devido à 
capacidade conhecida destes solventes em estabelecerem pontes de hidrogénio. Por outro 
lado, a sonda apresentou sempre um decaimento de intensidade de fluorescência mono-
exponencial, com um tempo de vida próximo de 3.9ns em todos os solventes estudados, 
excepto em glicerol. A medição de espectros de emissão resolvidos no tempo (TRES) 
confirmou que os decaimentos complexos apresentados pelo fluoróforo livre em glicerol 
eram devidos a um efeito de relaxação do solvente devido à sua viscosidade elevada. Ainda 
nesta fase, o espectro de excitação da anisotropia em estado estacionário da sonda foi 
medido em glicerol para se obter o valor da sua anisotropia fundamental em função do 
comprimento de onda de excitação. Com os dados obtidos, foi possivel (i) concluir que os 
momentos dipolares das transições S1So e S2So da sonda HL488 estão orientados 
perpendicularmente entre si, e (ii) prever assim o impacto da necessidade de se usar 
diferentes comprimentos de onda de excitação nas medidas de anisotropia em estado 
estacionário e resolvidas no tempo nos estudos que foram realizados posteriormente. 
O comportamento obtido para a variação das propriedades espectrais de ambos os 
péptidos derivatizados com o solvente usado foi muito idêntica à descrita anterioremente 
para a sonda livre HL488. No entanto, os péptidos sCT-HL488 e hCT-HL488 apresentaram 
agora um decaimento de intensidade de fluorescência complexo na maioria dos solventes 
estudados, embora sempre com uma componente dominante com ~3.9ns (com 
contribuição variável para a intensidade de fluorescência total consoante o solvente). Este 
comportamento foi discutido em termos da possibilidade de ocorrência de um mecanismo 
de extinção de fluorescência (quenching  estático ou dinâmico) da sonda usada devido a 
um processo de transferência electrónica fotoinduzida (PET) por possíveis resíduos de 
aminoácidos presentes no esqueleto polipeptídico das CTs. A conformação adoptada pelos 
polipéptidos, assim como as flutuações dinâmicas da cadeia polipeptídica, são altamente 
dependentes da polaridade e viscosidade do solvente, influenciando a eficiência dos 
mecanismos PET, que caracteristicamente decorrem do estabelecimento de interacções de 
curto alcance. Finalmente, constatou-se que o estado de agregação de ambos os péptidos 
em solução aquosa não variava numa gama alargada de concentrações (1nM to ~8μM) 
pois a sua anisotropia de fluorescência em estado estacionário era constante.  
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A redução da ponte persulfureto também não influenciou de modo dramático a dinâmica 
rotacional de ambos os polipéptidos derivatizados em solução aquosa, tendo-se concluído 
que estes adoptavam uma conformação relativamente compacta a partir da realização de 
medidas de anisotropia resolvidas no tempo. 
Por último, os péptidos derivatizados foram usados em estudos de partição através da 
realização de medidas da sua fluorescência extrínseca em estado estacionário e resolvidas 
no tempo. Foi avaliado o impacto da concentração de péptido no sistema, assim como da 
composição lipídica das membranas: usaram-se lipossomas compostos por POPC com 
proporções variáveis de POPS (0, 10, 20 e 30 mol%), que foram adicionados a uma 
concentração fixa de sCT-HL488 ou hCT-HL488 em tampão HEPES-KOH, pH 7.4. Tal como 
se verificou nos estudos em que se explorou as propriedades de fluorescência intrínseca 
da hCT, não houve qualquer tipo de alteração espectral nas medidas de absorção UV-VIS 
ou emissão fluorescência, assim como na variação da anisotropia em estado estacionário, 
com o aumento da concentração de vesiculas de POPC:POPS 70:30 nos estudos realizados 
com o péptido humano (1μM  hCT-HL488). Mesmo aumentando a carga negativa das 
vesiculas para 50% (POPC:POPS 50:50) não se observou qualquer interacção do péptido 
com as membranas. Mostrou-se assim que carga negativa promovida pelo POPS não é 
suficiente para desencadear uma ligação do péptido humano às membranas, e que os 
mecanismos de interacção descritos na literatura se devem provavelmente a variações na 
composição lipídica, como a inclusão de colesterol e/ou gangliósidos nas membranas, que 
têm a capacidade de potenciar as interacções membrana-péptido.  
O mesmo desenho experimental, utilizando-se agora sCT-HL488 (0.2, 1μM e 3.4μM) 
mostrou um desvio para o vermelho no seu espectro de absorção UV-VIS com o aumento 
da concentração de vesiculas contendo proporções variáveis de POPS (10, 20 e 30 mol%) 
associado à mudança de polaridade do microambiente da sonda covalentemente ligada. 
Em concordância, o valor de anisotropia em estado estacionário e da anisotropia residual 
revelaram também um aumento em função da adição de vesiculas ao meio, revelando 
assim adsorção do péptido às membranas aniónicas. O coeficiente de partição estimado a 
partir da variação do valor de anisotropia em estado estacionário mostrou aumentar em 
função da percentagem de POPS presente nas vesiculas, indicando que as interacções 
electrostáticas são as principais responsáveis pela interacção membrana-péptido. 
Recuperou-se ainda um valor de 𝐾𝑝 = (3.1 ± 0.2)x10
5 e 𝐾𝑝 = (2.9 ± 0.3)x10
5 nos estudos 
realizados com 1.0 e 3.4μM de sCT-HL488, respectivamente, na interacção com vesiculas 
de POPC:POPS 80:20.  
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Sendo este valor muito semelhante ao valor recuperado anteriormente nos estudos com a 
fluorescência intrínseca, é um indicativo de que a ligação da sonda ao péptido não altera 
significativamente a sua partição para as membranas.  
A emissão de fluorescência em estado estacionário de 1 e 3.4μM de sCT-HL488 em 
interacção com LUVs de POPC contendo 20mol% de POPS mostrou um comportamento 
bifásico, com um decréscimo acentuado para ~80 e ~60%, respectivamente, do valor 
inicial em solução aquosa, quando baixas concentrações de lípido foram adicionadas ao 
sistema. Com o aumento da concentração de vesiculas em solução, o valor de emissão de 
fluorescência foi progressivamente recuperado. Concomitantemente, o valor médio do 
tempo de vida de sCT-HL488, para ambas as concentrações utilizadas, não variou 
significativamente com o aumento da concentração de lípido. Estes resultados mostraram 
que, para concentrações de péptido em solução elevadas (relativamente à concentração de 
vesiculas aniónicas), a sCT-HL488 sofre quenching estático, indicando a formação de 
complexos escuros na superfície membranar. Adicionalmente, foi ainda possível 
identificar o estabelecimento de interacções excitónicas (formação de agregados tipo H) 
sob as mesmas condições experimentais, corroborando a formação de agregados de sCT-
HL488 na membrana. 
Utilizando concentrações mais baixas de sCT-HL488 (0.2μM), observámos ainda que o 
método de preparação das amostras influenciava criticamente a sua cinética de interacção 
com as membranas lipídicas aniónicas. Apesar de debatida, a razão por detrás deste 
comportamento não foi completamente esclarecida.  
Em resumo, mostrou-se que, apesar de a calcitonina humana não interactuar com 
membranas aniónicas, estas têm a capacidade de induzir a partição de sCT-HL488 
acoplada a um mecanismo de oligomerização dependente da concentração de péptido e de 
lípido no sistema, como já descrito na literatura para outros tipos de péptido. 
Concentrações de péptido críticas levam à agregação de monómeros na superfície das 
membranas aniónicas que não são fluorescentes. A identificação deste tipo de 
intermediários oligoméricos pode ter um papel importante na via de fibrilhação da CT 
mediada por membranas e/ou contribuir directa ou indirectamente para a sua toxicidade 
celular. 
Palavras-chave 
Calcitonina de salmão, Calcitonina humana, Hilyte Fluor 488, Espectroscopia de 
fluorescência, Fibras Amilóides, Interacção lípido-proteína, Modelo de Membranas
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LIST OF ABBREVIATIONS/ACRONYMS 
The acronyms used are expanded on first usage and whenever seemed necessary to 
improve clarity. Amino acid residues in the text are indicated using the three letter code, 
but primary sequences are indicated using the one-letter code to simplify. 
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1. INTRODUCTION 
The extracellular accumulation of insoluble aggregates of proteins/peptides generically 
designated as amyloid fibrils is a hallmark of a wide variety of devastating human 
disorders classified as protein misfolding or amyloid diseases (Chiti & Dobson 2006). 
These pathologies are widespread and include maladies like Alzheimer’s disease, Type II 
diabetes Mellitus and Parkison disease, as well as other major conditions including 
Chronic Traumatic Encephalopathy and Huntington’s disease (Nath & Rhoades 2013). 
These diseases represent a major health problem, which most probably will overwhelm 
the health systems of developed countries in the near future (Quintas 2013). Most of these 
so-called amyloid diseases are predominantly sporadic and result from defects in the 
conformational folding of specific proteins that leads to their pathological self-assembly 
and deposition, producing amyloid fibrils in the brain or in several other tissues (Chiti & 
Dobson 2006; Quintas 2013).  There is therefore a urgent and significant clinical interest 
in understanding the factors that trigger the pathological self-assembly of amyloid 
proteins/peptides and in the development of pharmacological tools by which these 
diseases may be arrested or diminished, being the misfolding and aggregation of these 
proteins a key step in the development of these disorders. 
 
1.1. PROTEIN FOLDING AND AMYLOIDOGENESIS 
After synthesis of their primary sequence in the ribosome, newly synthesized proteins are 
packed via intramolecular contacts into their native structure acquiring a unique three-
dimensional conformation (Figure 1.2).  Protein folding is a complex process that does not 
follow a specific pathway but presents different routes towards the native structure, in 
which the global free energy progressively decreases with the adoption of a more ordered 
structure, reaching their energy minimum in the native three-dimensional conformation 
(Figure 1.1) (Hartl & Hayer-Hartl 2009).  Thus, the pathway of protein folding consists of a 
series of sequential steps between increasingly native-like species, until the final native 
structure is formed. However, under some conditions proteins tend to expose their 
hydrophobic amino acid residues and do not fold correctly into their native structure, 
leading to misfolded states that can cause malfunctions and lead to the early mentioned 
amyloid diseases (Figure 1.2), This can be seen as a modification in the protein folding 
pathway according to the free energy landscape theory as illustrated in Figure 1.1. 
 
 
Introduction 
22 
 
The possible factors that might modulate the features of the protein free energy landscape 
are the amino acid sequence, pos-translational modifications, ligands, cofactors and 
environmental condition. Misfolded proteins are thermodynamically unstable and present 
a high tendency to aggregate (self-assemble) into amorphous aggregates that can evolve 
to highly ordered filamentous structures called amyloid fibrils. The term “amyloid” has 
been historically referred to misfolded proteins that deposit in tissues as filamentous 
structures (amyloid fibrils) due to their propensity to aggregate. Accumulating evidence 
leads support to the hypothesis that structural transformation of a polypeptide chain into 
a partially folded conformation is a critical prerequisite for fibril formation (Kelly 1998; 
Rochet & Lansbury 2000; Gorbenko & Kinnunen 2006), but this process can also occur 
from native-like conformations (Chiti & Dobson 2009). Complete protein unfolding does 
not appear to be necessary, but some structural flexibility is needed in order for 
aggregation to occur. However, protein aggregation is not promoted by the least ordered 
regions but by particular aggregation-prone sequences, such as those having a high 
hydrophobicity (Relini et al. 2013). 
 
 
Figure 1.1: A schematic energy landscape for protein folding and aggregation. The surface shows 
the multitude of conformations ‘funnelling’ towards the native state via intramolecular contact 
formation, or towards the formation of amorphous aggregates or more organized amyloid fibrils via 
intermolecular contacts. [Adapted from (Jahn & Radford 2005)]. 
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Several proteins implicated in amyloid diseases, such as Aβ peptides in Alzheimer’s 
disease, amyloid islet protein (hIAPP) in Type II diabetes, and α-synuclein in Parkinson’s 
disease, are intrinsically disordered proteins (IDPs) (Relini et al. 2013). Unlike globular 
proteins, the energy landscapes of IDPs do not show one deep local minimum but are 
much shallower with many minima without intrinsic large energy barriers (Uversky 
2013). Thus these proteins can easily sample many conformations. As an example, kinetic 
studies on prokaryotic hydrogenase maturation factor (HypF-N) have shown that under 
slightly destabilizing conditions, where the protein is still predominantly in its native 
state, the population of molecules in a partially folded state increases, and it is this state 
that is responsible for increased aggregation under these conditions (Marcon et al. 2005). 
A variety of biophysical methods has provided experimental evidence that this 
intermediate is much more likely to aggregate than the native state (Rennella et al. 2013). 
These partially folded intermediates can thus act as links between folding and aggregation 
landscapes (Figure 1.1) 
 
 
Figure 1.2: Schematic representation of some conformational states that can be adopted by 
polypeptide chains. Polypeptide chains evolve from an unfolded state to a native or misfolded state, 
but not all aggregated states should be denoted with an amyloid disease. Recently even functional 
fibers have been found in living systems. [Adapted from (Hipp et al. 2014)]. 
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1.1.1. AMYLOID FIBRIL STRUCTURE  
Until few years ago, there was a general agreement on the idea that only a limited number 
of proteins could form “amyloids”. However it has recently been demonstrated that almost 
every protein has segments that can assemble into amyloid fibrils, so the ability to form 
these structures is not limited to proteins associated with conformational diseases 
(Gorbenko & Kinnunen 2006; Diociaiuti et al. 2011). All complex proteins have segments, 
with are typically six amino acids long, which can be exposed when a protein partly 
unfolds and promote its aggregation.  
One of the striking characteristics of the amyloid diseases is that the filamentous 
structures formed are very similar in their overall properties (highly stable and insoluble) 
and appearance, forming a β-cross structure in which continuous β-sheets are formed 
with β-strands running perpendicular to the long axis of the fibril (Figure 1.3) (Jahn & 
Radford 2005; Chiti & Dobson 2006; Bellotti & Chiti 2008). Backbone hydrogen bonds are 
parallel to the axis and stabilize the overall structure. These structures are resistant to 
proteases and some molecular probes like Thioflavin T (ThT) and Congo Red (CR) can 
specifically bind to intermediates and mature amyloid fibrils (Ryan et al. 2008). 
 
Figure 1.3: Representation of polypeptide chains in amyloid fibrils. Hydrogen bonds are formed 
between the parallel and anti-parallel polypeptide chain producing perpendicular twisted β-sheet 
chains along to the axis of the fibril. [Adapted from (Vilar et al. 2008)] 
It is now generally agreed that the pathogenic aggregates are not the mature fibrils, but 
the intermediate soluble oligomers (Gorbenko & Kinnunen 2006; Diociaiuti et al. 2011). It 
has been proved that oligomers of different amyloid proteins not associated with any 
disease are also neurotoxic and share a surprising structural and functional similarity, 
suggesting that a shared structural feature of these is at the basis of their neurotoxicity.  
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In the case of the fibrils, oligomers often have a β-sheet structure (Relini et al. 2004; 
Chimon et al. 2007; Ono et al. 2009), but cases in which they are composed of loosely 
aggregated β-strands have also been reported (Ahmed et al. 2010). The direct cytotoxicity 
of pre-fibrillar amyloid assemblies has been confirmed for all proteins and peptides 
associated with amyloid diseases, including Aβ peptides, α-synuclein, IAPP and other 
(Conway et al. 2000; Poirier et al. 2002; Cleary et al. 2005) and also for many not 
associated with any disease (Bucciantini et al. 2002; Sirangelo et al. 2004). The use of 
antibodies in some studies has revealed the existence of distinct families of amyloid 
oligomers possibly with different cytotoxicity (Glabe 2008). 
Mutations that increase hydrophobicity or decrease charge often increase the rate of 
misfolding to amyloid structures, as well as mutations that increase the likelihood of the 
sequence to adopt a β-sheet structure (Chiti et al. 2002). Both these situations make it 
more likely that protein molecules will interact with each other and aggregate. In addition, 
Kim and Hecht found a strong correlation between aggregation and both hydrophobicity 
and propensity to adopt a β-sheet structure (Kim & Hecht 2005). 
1.1.2. AMYLOID FIBRILATION FORMATION KINETICS 
Protein fibrillization is an extremely complex process, commonly involving kinetic 
competition between formation of amorphous aggregates and fibrillar species, a variety of 
intermediates, multiple conformational states, and a number of filamentous forms (Figure 
1.2). The experimentally observed sigmoidal profile characteristic of a fibrillogenesis 
kinetics is usually interpreted as a Nucleation Dependent Polymerization (NDP) model, in 
which protein assembling into fibrillar structures can be divided in three stages: (i) the 
initial slow nucleation (lag phase) where the monomers associate into critical oligomeric 
nucleus, being the highest energy state and thus the thermodynamically unfavourable 
species along the polymerization pathway, followed by (ii) an elongation phase, where the 
elongation of the nucleus via the attachment of additional monomers becomes 
energetically favourable, thereby resulting in exponential fibril growth, leading to a (iii) a 
plateau phase, where mature and large amyloid fibrils take over (Gorbenko & Kinnunen 
2006; Butterfield & Lashuel 2010)(Figure1.4). The process is time-dependent and 
proceeds through the formation of dimers, trimers, tetramers and different kinds of proto-
fibrils until reaching the final insoluble fibrillar structure. 
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 Other mechanisms have been suggested to describe fibril formation by amyloidogenic 
polypeptides such as Diffusion-limited Aggregation model (Tomski & Murphy 1992), in 
which the monomers spontaneously convert to octamers and later stack into fibrils, the 
template assembly (TA), monomer-directed conversion (MDC), and nucleated 
conformational conversion (NCC) models (Kelly, 1998), in which two structurally distinct 
peptide states are considered, a soluble state that eventually converts into an assembly-
competent state by structural transitions. 
  
Figure 1.4: Illustration of nucleation-dependent polimerization mechanism for the amyloid fibril 
formation kinetics. [Adapted from (Butterfield & Lashuel 2010)] 
It is still unclear which conformational species is a direct precursor for fibril formation, 
but the involvement of partially folded structures that successively accumulate to a small 
amount in solution has been accepted (Lundberg et al. 1997; Raffen et al. 1999; Blackley et 
al. 2000). The rate of amyloid formation was found to be promoted by the addition of 
preformed fibrils for several amyloid proteins (seeding experiments) (Hamada & Dobson 
2002), a finding indicative of a nucleation-dependent process. 
1.2. THE ROLE OF BIOLOGICAL MEMBRANES ON AMYLOIDOGENESIS 
Recently, several studies have suggested that biological membranes can promote the 
pathological conversion of amyloidogenic proteins/peptides into toxic aggregate 
structures by providing a soft surface (Zhao et al. 2004; Butterfield & Lashuel 2010; Relini 
et al. 2013). These studies have shown that lipid-protein/peptide interactions can strongly 
modulate the amyloid fibril formation by decreasing the energy barrier for protein 
unfolding which leads to the instability of protein/peptide native states, promoting its 
misfolding and aggregation (Zhao et al. 2004; Gorbenko & Kinnunen 2006).  
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In fact, in vitro studies have demonstrated that surfaces in general have an aggregation-
inducing action and a direct role on the kinetics of aggregation. The fibrillation effect 
appears to correlate directly with the hydrophobicity of the surface (Bellotti & Chiti 2008). 
Thus, membrane surfaces can act as an effective two-dimensional catalyst of 
fibrillogenesis, depending on their lipid composition and biophysical features that arise 
from their chemical characterisitics, such as length of acyl chain, degree of unsaturation, 
the surface net charge, its phase state, bilayer curvature and the degree of hydration. 
1.2.1. LIPID-PROTEIN INTERACTIONS  
Cellular membranes are essential components of cells and have both functional and 
structural roles comprising three mains functions: (i) selective permeable barrier for 
exchange of matter, (ii) stable and fluid ground for reactions of liphophilic substances and 
proteins, (iii) exchange of energy and information with extra-cellular environment or with 
cytosol, in the case of organelles (Muller et al. 1996). So the membrane must be stable 
enough to maintain a permeability barrier while being sufficiently fluid to accommodate 
changes in shape or enclosed volume, which allows life to develop.  
The composition of the cellular membrane is extremely complex due to diversity of 
membranes proteins and several hundreds of different lipids species with differing head 
groups and unsaturation of the acyl chains that can be found in these structures (García-
Sáez & Schwille 2010). During the last decade it has become clear that lateral protein and 
lipid heterogeneities are important for a number of cellular processes. Lipid-protein 
interactions play a key role in a wide variety of cellular processes, including signal 
transduction, intracellular transport, enzyme catalysis, energy conversion in the cell, 
antimicrobial defence and control of membrane fusion.  
The chemical nature of the bilayer components and structural characteristics of the 
proteins/peptides in question is likely to have a significant role in determining the mode 
and extent of the membrane binding of proteins, as well as in the adoption of aggregation-
prone protein conformation. Depending on the membrane composition, groups of specific 
lipids may aggregate into patches with physical properties distinctly different from those 
of other membrane domains. 
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Anionic lipids appear to be especially important in membrane-assisted conformational 
changes and electrostatic interactions in protein-lipid interactions (Zhao et al. 2004). 
Anionic surfaces have been shown to promote protein aggregation and fibrillization since 
the high local concentration of protein on these surfaces overcomes the energy barrier for 
nucleation (King et al. 1999) showing that an increase in the local concentration of the 
protein in the membrane is essential for the modulation of fibrillization rate (Gorbenko & 
Kinnunen 2006). 
In general, the interaction of a peptide with the lipid membrane is initiated by the 
electrostatic attraction to the anionic membranes (Figure 1.5). Depending on the peptide 
charge and size relatively to the membrane surface, potential electrostatic attraction (or 
repulsion) will increase (or decrease) significantly the concentration of the peptide near 
the membrane surface (Seelig 2004). In many cases peptides are in a random coil 
conformation in solution and an α-helical conformation when associated with the lipid 
membranes. Depending on the relative peptide-to-lipid concentration, Aβ, IAPP and α-
synuclein have all been shown to shift to an α-helical structure upon membrane binding 
(Butterfield & Lashuel 2010). 
 
Figure 1.5: Molecular recognition at the membrane surface. The diagram shows different stages of 
peptide binding: the charged peptide is attracted electrostatically to the membrane surface 
followed by a conformational change of bound peptide. [Adapted from (Seelig 2004)] 
The anchoring of the aggregation-prone peptides to the anionic membrane will enhance 
the local protein concentration thus favour conformational switching to β-sheet and 
protein aggregation (Figure 1.6). This shared feature suggests a common mechanism for 
membrane-mediated misfolding of proteins/peptides and their subsequent self-assembly. 
In vitro conversion of IAPP, α-synuclein and Aβ peptides from a disorder monomeric 
peptide to highly ordered amyloid fibrils has been extensively studied (Nath & Rhoades 
2013) giving significant evidences for the role of anionic lipids in the amyloidogenesis 
catalysed by cellular membranes. 
Introduction 
29 
 
In the case of IAPP, several studies found that IAPP binding to membranes containing 
anionic lipids led to its conversion into an α-helical form and to eventual formation of β-
sheets and fibrillization (Jayasinghe & Langen 2005; Apostolidou et al. 2008; Knight et al. 
2008), leading to a decrease in the lag time and increasing the rate of fibrils growth. 
Fibrillization studies of IAPP induced by DOPC/DOPG (Knight & Miranker 2004) and in the 
presence of vesicles composed of zwitterionic (PC) and anionic (PG) phospholipids 
(Knight et al. 2008) has been demonstrated to exhibit a sigmoidal profile, with an initial 
lag phase of relatively slow fibril nucleation and a rapid elongation phase, during which 
the remainder of the soluble peptide was converted into amyloid, showing that the free 
energy contribution of the lipid bilayer to the transition state of fibril formation is 
determined by increasing the local peptide concentration. 
 
Figure 1.6: Schematic representation of amyloid fibril formation catalysed by an anionic lipid 
membrane. The binding process causes a conformational change of the membrane-bound peptide 
to an α-helical form that further shifts to a β-sheet-rich fibril upon increasing the local peptide 
concentration. [Adapted from (Fantini & Yahi 2010)] 
In the case of α-synuclein, interactions with anionic lipids cause both an increase in α-
helical content and aggregation (Jo et al. 2000; Davidson et al. 1998). The presence of 
membranes appears to make the helical conformation more stable.  Single molecule 
studies have also shown that in the presence of lipids, the energy landscape of α-synuclein 
acquires two local minima corresponding to two α-helical conformations, the favoured one 
depending on the concentration of the lipid and curvature of the vesicles (Ferreon et al. 
2009).  
In the case of Alzheimer peptides, binding to negatively charged lipids bilayers leads first 
to a β-structure (low lipid to protein ratio) and then to a α-helix formation (high lipid to 
protein ratio) (Seelig 2004). The preference of Aβ peptides to bind to anionic membranes 
is a recurring observation (Butterfield & Lashuel 2010).  
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It was demonstrated that Aβ40 inserts spontaneously into anionic DPPG rather than 
zwitterionic DPPC lipid monolayer (Chi et al. 2008) and PG-containing vesicles induced a 
β-sheet conformation in Aβ40 as well as peptide oligomerization (Wong et al. 2009). 
The changes in composition and physicochemical properties of lipid bilayer associated 
with aging or other physiological or pathological processes may increase membrane 
binding of specific proteins thereby triggering amyloidogenesis in vivo. Unfortunately, in 
spite of the significant progress in understanding how proteins attain their native state, 
we still know very little about the effects of the cellular environment on folding. 
1.2.2. MEMBRANES AS A TARGET OF AMYLOID-LIKE STRUCTURES 
It is commonly accepted that the interaction between amyloid aggregates and membranes 
results in disruption of the barrier function of the membrane, followed by intracellular 
calcium dysregulation and oxidative stress. Recently, it has been raised the possibility that 
a subpopulation of doughnut-shaped oligomers (amyloid pores) may account for amyloid 
toxicity. Early aggregates appearing as small annular rings with a central pore have been 
identify by electron microscopy (EM) and atomic force microscopy (AFM) in the 
fibrillization pathway of many proteins and peptides (Quist et al. 2005; Diociaiuti et al. 
2006). These findings support the channel hypothesis of amyloid toxicity stating that 
amyloid aggregates form non-specific pore-like structures in the membrane of the exposed 
cells impairing their selective permeability (Figure 1.7). 
This mechanism of toxicity is similar to those described for antibacterial toxins and viral 
proteins (hydrophobicity-based toxicity). Several models have been proposed to predict 
Aβ peptide ability to insert in the lipid bilayer and several pore arrangements were 
identified, all starting from a basic structure composed of a β-hairpin followed by a helix-
turn-helix motif (Durell et al. 1994; Mobley et al. 2004; Diociaiuti et al. 2011).  
Additionally, it has been widely demonstrated that the secondary structure of membrane 
bound Aβ peptide and its ability to insert into the bilayer are strongly affected by the lipid 
composition with particularly importance to the presence of “raft-like” lipid domains in 
the membrane.  
Other molecular mechanisms like the Carpeting model and Detergent-like effect were also 
proposed to explain the cytotoxicity created by amyloidogenic proteins/peptides 
(Reviewed in Relini et al. 2013 and Butterfield & Lashuel 2010).  
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The Carpeting model suggests that that the oligomers or other prefibrillar species bind to 
the outside leaflet of the membrane producing an asymmetric pressure between the two 
leaflets and finally leading to outflow of small molecules (Hebda & Miranker 2009). Some 
studies reported membrane thinning and nonspecific membrane permeabilization, 
supporting this model. In the Detergent-like effect, the amyloid precursor act as a 
surfactant and can uptake lipids from the membranes, leading to membrane thinning and 
possible transient holes. It was found that the assembly of IAPP fibrils at the membrane 
causes disruption by extracting lipids and incorporating them into emerging fibril trough a 
detergent-like mechanism (Sparr et al. 2004). 
 
Figure 1.7: Different pathways of amyloidogenic protein oligomerization and fibrillation on 
membrane surfaces illustrating the channel hypothesis. Upon interaction with anionic membranes, 
unstructured soluble monomers undergo an α-helix shift of their conformation. Further 
accumulation of the proteins on the surface of the membrane induces their oligomerization into β-
sheet aggregates or α-oligomers. Oligomers can form protofibrils, amyloid fibrils and amyloid pores 
(annular protofibrils) with ion-channel properties. [Adpated from (Fantini & Yahi 2010)]. 
So far, the major unsolved problem remains the molecular mechanism whereby the 
barrier properties of the cells are hampered. Although many models have been proposed 
in the literature, the molecular mechanisms for toxicity have not been entirely solved. 
More than one mechanism might be active in increasing the ionic fluxes, which cause 
interference with ion homeostasis and the toxic cascade of events associated with amyloid 
diseases.  
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1.3. CALCITONIN AS A MODEL PEPTIDE 
Calcitonin (CT) is a polypeptide hormone released by the C cells in the thyroid gland 
which plays an important role in calcium metabolism (Figure 1.8) (Arvinte & Drake 1993; 
Wang et al. 2005; Itoh-Watanabe et al. 2013). The major physiological role of CT is to 
control the calcium concentration in the body, reducing the amount of calcium in the blood 
stream. CT reduces the amount of calcium excreted by the bone, inhibiting the osteoclast 
activity and decrease bone reabsorption. Its production is inhibited when the calcium 
concentration is decreased beyond normal levels and the parathyroid hormone (PTH) is 
then secreted, which promotes the opposite reactions to CT in the body. These two 
hormones act to maintain a normal concentration of calcium in the bloodstream.  
 
Figure 1.8: Calcium Homeostasis. CT reduces the amount of calcium excreted by the bone, inhibiting 
the osteoclast activity and decrease bone reabsorption. In response to declines in serum calcium, 
the parathyroid glands secrete parathyroid hormone (PTH). PTH stimulates the release of Ca2+ 
from bone, increasing bone resorption. Therefore, these two hormones act to maintain a normal 
concentration of calcium in the bloodstream. [adapted from http://newdrugapprovals.org. 
Consulted on 2014/09/24]. 
The primary sequence of the calcitonin has been determined for many species (including 
human, sheep, rat, pig, salmon and eel calcitonins) and differ mainly in the sequence of 
amino acids forming the central portions of the polypeptide (Diociaiuti et al. 2011). It has 
been found that salmon (sCT) and eel (eCT) calcitonins are more potent than the actual 
human calcitonin (hCT) (Torres-lugo & Peppas 2000).  
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The reason for this phenomenon is still not fully understood. The basic structure of the CT 
is characterized by a primary sequence of 32 amino acids and a disulfide bridge between 
the cysteine residues at positions 1 and 7 (Figure 1.9). CT has been administered in the 
treatment of bone diseases such as Paget’s disease, hypercalcemia, osteoporosis (Torres-
lugo & Peppas 2000) and other metabolic bone diseases due to its ability to reduce 
osteoclast activity. The use of hCT has been limited by its high tendency to self-associate in 
the form of amyloid fibrils in aqueous solution (Kanaori & Nosaka 1995; Bauer et al. 1994; 
Itoh-Watanabe et al. 2013) and because it has been associated with medullary carcinoma 
of the thyroid. The high potency of sCT and lower tendency to self-associate made it a 
more suitable target for drug development for treatment of osteoporosis as an alternative 
to hCT.  
 
Figure 1.9: Illustration of the primary sequence of 32 amino acids of salmon calcitonin. A disulfide 
bridge is present linking Cys1 and Cys7. The differences between salmon and human calcitonin are 
described in the next chapter [Adapted from (Andreassen et al. 2014)]. 
It has been shown that both hCT and sCT can aggregate in solution over time (Kanaori & 
Nosaka 1995; Wang et al. 2005; Diociaiuti et al. 2011; Itoh-Watanabe et al. 2013), starting 
with the formation of oligomers which eventually results in the deposition of fibrils and 
plaques. hCT tends to aggregate in aqueous solution more rapidly than sCT, and this 
difference was attributed to the different pK values (8.7 and 10.4 for hCT and sCT, 
respectively) with one positive charge for hCT and three positive charges to sCT at pH 7.4 
(Diociaiuti et al. 2011).  
Thus, sCT is characterized by a very slow aggregation rate which makes it a suitable tool to 
be used in the study of molecular mechanisms of amyloid formation with particular 
attention to the early stages of aggregation, when the oligomers are produced, and to their 
possible interaction with cell membranes.  
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Some studies showed that in aqueous solution sCT and hCT are in a random coil 
conformation, but in the presence of organic solvents or phospholipids, they easily acquire 
a α-helix secondary structure (Arvinte & Drake 1993; Diociaiuti et al. 2011). The 
interaction of sCT (Diociaiuti et al. 2006; Diociaiuti et al. 2011) and hCT (Stipani et al. 
2001) with model membranes demonstrates that incorporation in the lipid layer leads to a 
dramatic conformational change towards β-structure and this change was correlated to 
the observation of the membrane permeability and pore-like structures that could form 
ion channels in osteoblast plasma membrane, leading to calcium influx. These 
observations were completely dependent on the lipid composition of cell membranes, 
namely the presence of chol/DPPC/GM1 domains favoured the binding process. 
Additional evidence showed that the fibrils of hCT and bovine calcitonin (bCT) were toxic 
in cell cultures (Rymer & Good 2001) and that bCT conformation is highly affected by the 
membrane environment (Wang et al. 2005). In the presence of oxidizing agents in solution 
and in the presence of lipid rafs (liposomes containing cholesterol and GM1), sCT shows an 
instant change in the secondary structure to β-rich conformation (Diociaiuti et al. 2011). 
On the other hand, N-terminally truncated derivatives of hCT, lacking hormonal activity, 
represent a novel class of weakly cationic cell penetrating peptides (CCPs) which have 
been systematically investigated (Herbig et al. 2005). CPPs have been suggested as vectors 
for cytoplasmic and nuclear delivery of hydrophilic biomolecules and drugs. 
1.4. OBJECTIVES AND EXPERIMENTAL STRATEGY 
The ability of anionic lipid membranes to induce the formation of amyloid-like assemblies 
by non-amyloidogenic proteins under conditions close to physiological has been an 
important research line over the last couple of years at the host laboratory (Melo et al. 
2011; Melo et al. 2013; Melo et al. 2014). This work further extends this topic since it is 
part of a larger project aimed at elucidating the role that accessory cellular components, 
like biological membranes and glycosaminoglycans, can play in the modulation of amyloid 
pathologies.  
The major goal of this study was to use CT as a model polypeptide to gain a detailed 
molecular description about the ability of negatively-charged lipid membranes in 
modifying the aggregation pathway of this polypeptide in solution, which was being 
studied in parallel by another lab member. Full-length (residues 1-32) CT peptides 
prepared with the human and salmon amino acid sequences were both used here.  
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hCT in an ideal model since it is considered an amyloid polypeptide due to its high 
tendency to self-associate, which leads to the formation of oligomers, and eventually 
results in the deposition of fibrils, as described in the last section. On the other hand, sCT 
has been the clinically preferable alternative to hCT for several years because of its 
substantially lower propensity to aggregate. Therefore, the salmon sequence of CT is 
expected to be mechanistically informative about the fibrillogenesis kinetics undergone by 
the full-length hCT, as it is anticipated to sample intermediate-like states and to form 
amyloid fibrils in a much longer time scale (Diociaiuti et al. 2011). 
Both unlabelled and fluorescently-labelled hCT and sCT polypeptides, which were 
covalently conjugated to a very bright and photostable fluorophore - HiLyte 488 (HL488) 
– at their N-terminal, were employed in this study. This labelling position was chosen to 
minimize the possibility that the dye might interfere with the formation of a -structure 
since this is known to involve the C-terminus (25-32) of the polypeptide sequence 
(Jonsson et al. 2008; Jha et al. 2012). In this way, by exploring the intrinsic and extrinsic 
fluorescence properties of these polypeptides using both steady-state and time-resolved 
fluorescence measurements, we specifically sought: (i) to characterize the aggregation 
state of both the unlabelled and HL488-labelled CT variants in aqueous solution; (ii) to 
study the influence of lipid composition, particularly the anionic lipid content of the 
liposomes, on both the unlabelled and HL488-labelled CT variants binding to the lipid 
vesicles; (iii) to evaluate the changes in the oligomerization state of the HL488-labelled CT 
variants on the membrane surface as a function of the peptide-to-phospholipid (P/L) 
molar ratio used. 
Fluorescence is an extremely versatile spectroscopy as exemplified by the array of 
fluorescence parameters that can be explored in a single experiment (fluorescence 
intensity, spectral distribution, lifetime and anisotropy). Each of these parameters can be 
used as a sensitive reporter of distinct aspects related to the mechanism of action of CTs at 
the membrane level, like their membrane partition coefficients, location, rotational 
dynamics and self-assembly (Munishkina & Fink 2007; Nath & Rhoades 2013). 
Furthermore, due to the high sensitivity and specificity of this technique only trace 
amounts of the fluorescently-labelled peptides are eventually needed to be used in the 
experiments which, in turn, will enable the performance of co-mixing assays with 
unlabelled peptide, minimizing the chances of labelling interference in the process under 
study. 
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The model membrane systems used in this work were always large unilamellar vesicles 
(LUVs) prepared with a variable lipid composition. In fact, from the three main types of 
phospholipid vesicles (small, large and giant unilammelar vesicles) also referred as 
liposomes, composed by a single bilayer, LUVs have been a popular scaffold for monitoring 
peptide-membrane interactions in general due to its suitable diameter (around 100nm) 
and degree of curvature (Mäler & Gräslund 2009). Given their spherical shape and water 
filled interior, vesicles are thought to be the most biologically relevant mimic of natural 
cell membranes (Butterfield & Lashuel 2010). The phospholipids used in this study were 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoserine (POPS), which were chosen as representatives of a zwitterionic 
and an anionic unsaturated phospholipid, respectively.  
Both hCT and sCT are intrinsically fluorescent peptides due to their aromatic residues 
(Tyr12, Phe16, Phe19, Phe22 and Tyr 22 are present in hCT and sCT, respectively) (Figure 
2.1). Therefore, the ability of the intrinsic fluorescence properties of both sCT and hCT on 
reporting their binding to anionic lipid membranes (POPC:POPS 80:20 LUVs) was first 
evaluated in this work. The results obtained in this section were also a useful control of 
the possible impact exerted by the extrinsic fluorophore HL488 on the partitioning 
properties of both CT variants. 
In the second part of this study, the extrinsic fluorescence properties resulting from the 
covalent conjugation of the HL488 fluorophore to the N-terminal of both CT variants were 
then used to study their interaction with POPC LUVs containing a variable anionic lipid 
content (0, 10, 20 and 30mol% POPS, respectively). Since this fluorophore is only recently 
available commercially, there is not much information about it in the literature. Therefore, 
a brief characterization of several spectroscopic properties presented by both the free 
HL488 dye and the HL488-labeled CT variants was first made in a small set of solvents, 
namely several alcohols with variable lengths of aliphatic chain (methanol, ethanol, 
propanol and butanol) and two fluoro alchools (1,1,1,3,3,3-hexafluoro-2-propanol and 
2,2,2-trifluorehtanol).  
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2. MATERIALS AND METHODS 
2.1. REAGENTS AND STOCK SOLUTIONS 
Calcitonin Peptides and Free Dye: Synthetic unlabeled and labeled human and salmon 
calcitonin (hCT and sCT, respectively) incorporating HiLyte Fluor 488 (sCT-HL488 and 
hCT-HL488, respectively) were purchased from AnaSpec (Table 2.1) and used without 
additional purification. Fluorophore attachment to the N-terminus position of the 
calcitonin peptides was performed by the manufacturer. The percentage of singly-labeled 
calcitonin peptide was measured by the manufacturer using mass spectroscopy (MS) and 
high-performance liquid chromatography (HPLC), and was reported as 95% for all 
batches used in this work (Table 2.1). All calcitonin peptides contain a disulfide bridge 
between Cys-1 and Cys-7 in the primary sequence and their C-terminal is amidated 
(Figure 2.1). The free dye HiLyte Fluor 488 acid, succinimidyl ester (HL488) was also 
obtained from AnaSpec (catalogue #81161). Although its chemical structure has not yet 
been disclosed by the manufacturer, the overall charge of the dye is known to be +1 
(Figure 2.1). The lyophilized peptides and free dye were kept frozen at -20C. 
 
Figure 2.1: (A) Comparison between the primary sequences of human (hCT) and salmon (sCT) 
calcitonin variants. (B) Chemical structure of Hilyte Fluor 488 [adapted from (Jungbauer et al. 
2009)]. 
It is important to start the studies from a monomeric solution of peptides as the presence 
of preformed aggregates can seed its oligomerization in solution. It has been shown that 
treatment of peptides with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) can remove pre-
existing aggregates (seeds) in solution (Andreotti et al. 2011).  
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Therefore, the stock solutions of unlabeled and fluorescently labeled sCT and hCT were 
usually prepared by directly dissolving 1 mg of the lyophilized powder in 200µL of pure 
HFIP to a final concentration of about 1mM. After a brief sonication step in a bath 
sonicator (Branson) of about 1 minute at room temperature (RT), the peptide stock 
solutions were stored at -20C. The HL488 stock solution was prepared by directly 
dissolving the free dye in ethanol.  
 
Table 2.1: Additional information for the synthetic fluorescently labeled and unlabeled human and 
salmon calcitonins obtained from AnaSpec. The counter ions were trifluoroacetate for all peptides. 
1 determined by % peak area in HPLC analysis 
The stock solutions were quantified spectrophotometrically using a molar absorption 
coefficient of 1615 M-1cm-1 at 280 nm for the unlabeled CTs and 70 000 M-1cm-1 at 502 nm  
for both the free dye and the HL488-labeled calcitonins as provided by the manufacturer. 
The molar absorption coefficient for the unlabeled peptides at 280 nm, 𝜀(280), was 
calculated accordingly to Pace et al. (Pace et al. 1995), using the following equation based 
on the number of tryptophan (#Trp), tyrosine (#Tyr) and disulfide bonds(#cys) present 
in each peptide sequence:     
 𝜀(280)(M−1cm−1) = (#𝑇𝑟𝑝)(5,500) + (#𝑇𝑦𝑟)(1,490) + (#𝑐𝑦𝑠)(125) [2.1] 
Phospholipids: 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS) (Figure 2.2) were obtained from 
Avanti Polar Lipids. The lyophilized phospholipids were stored frozen at -20C. 
Approximately 20 mM stock solutions of POPC and POPS were prepared in chloroform and 
stored at -20C. The exact concentration of each stock solution was determined using 
phosphate analysis (McClare 1971). 
Reagents 
[M+H+] 
(g mol-1) 
 
Purity 1 
Net 
charge 
Catalogue number 
Theoretical Mass Determined by MS  
sCT 3432.9 3431.5  95% +3 87666 
hCT 3418.1 3419.2  98% +1 76191 
sCT-HL488 3788.4 3790.0  98% +3 Custom Synthesis 
hCT-HL488 3774.4 3774.3  96% +1 Custom Synthesis 
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Other reagents: Ethylenediamine-N,N,N’,N’-tetraacetic acid (EDTA) and potassium 
hydroxide were obtained from Merck; HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), insulin from bovine pancreas and N-acetyl-L-tyrosinamide 
(NAYA) were purchased from Sigma-Aldrich; L-tyrosine was obtained from Fluka and 
fluorescein was purchased from Molecular Probes, Invitrogen. All other chemicals were 
purchased from Sigma-Aldrich, unless otherwise stated. All reagents had purity grade 
higher than 95% and were kept at RT. 
 
Figure 2.2: Molecular structures of (A) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
and (B) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS) [Adapted from avantilipids.com 
accessed August 2014]. 
Buffers: The main buffer system employed in this work was 20 mM HEPES-KOH, 0.1 mM 
EDTA, pH 7.4 (HEPES-KOH buffer, pH 7.4). A high ionic strength buffer was also used in 
some studies (20 mM HEPES-KOH, 0.1 mM EDTA, 150 mM NaCl, pH 7.4). Buffer solutions 
were prepared using ultrapure water, obtained from a Milli-Q system (>18 MΩ·cm) and 
stored at 4C. All buffer solutions were always filtered with 0.22 µm cellulose acetate 
filters (Millipore) prior to sample preparation.  
Solvents: Chloroform, HFIP, ethanol and 2-propanol were obtained from Merck; 2,2,2-
trifluorehtanol (TFE) was obtained from Fluka; glycerol and methanol were purchased 
from Sigma-Aldrich. All solvents were of spectroscopic UVasol grade or purity grade 
higher than 99%. Table 2.2 summarizes additional information for the solvents used. 
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Table 2.2: Solvent Properties: Dielectric constant, ε. viscosity, η, and refractive index, n, of the 
solvents used in this work (T= 20C) (Lakowicz 2006; Haidekker et al. 2005). 
 
 
 
 
 
 
2.2. SPECTROSCOPIC STUDIES IN HOMOGENEOUS MEDIUM 
Each peptide- and free dye-containing sample was prepared independently, usually just 
before the spectroscopic measurements, by evaporation of the organic solvent (HFIP and 
ethanol, respectively) from the required volume of the stock solution using a nitrogen 
flow. In each case, the stock solution of the peptide in HFIP and HL488 in ethanol were 
allowed to thermally stabilize at RT for 10 min. Additionally, the stock solution of the 
peptide was sonicated for approximately 1 min in a bath sonicator prior to its use. The 
films were subsequently re-suspended in HEPES-KOH, pH 7.4 buffer or in other solvent to 
a final concentration of approximately 0.8μM and 1μM (unless otherwise mentioned) for 
peptide and free dye, respectively. Particularly, for free dye-containing  samples prepared 
in glycerol each sample was incubated at RT overnight with magnetic stirring to ensure a 
complete homogeneity of the system, due to the high viscosity of the solvent. 
2.3. INTERACTION WITH ANIONIC LIPID VESICLES                                               
2.3.1. PREPARATION OF LARGE UNILAMELAR VESICLES 
Large unilamellar vesicles (LUVs) were prepared by the extrusion technique (Mayer et al. 
1986). The adequate volumes of each phospholipid stock solution were mixed in a round 
bottom flask in order to prepare lipid mixtures containing POPC and 0, 10, 20 or 30 mol% 
of POPS, respectively. After submitting the samples to a N2 flow, they were kept overnight 
under an oil pump vacuum to remove any residual solvent.  
Solvent ε  
η  
(mPa·s) 
n 
Water 80.4  1.00 1.33 
Methanol 33.1  0.59 1.33 
Ethanol 25.1  1.20 1.36 
Propanol 21.7  1.94 1.39 
Butanol 17.9  2.54 1.40 
Glycerol 47.0  945 1.47 
HFIP 57.0  1.65 1.28 
TFE 26.1  1.75 1.29 
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Each lipid mixture was then re-suspended in HEPES-KOH buffer, pH=7.4 and submitted to 
several vortex cycles for a couple of seconds in order to remove the entire lipid film from 
the flask wall. The resulting lipid dispersions were equilibrated by 10 freezing and melting 
cycles using liquid nitrogen and a 50C water bath. Finally, the lipid suspensions where 
extruded 21 times through 100 nm pore size polycarbonate membranes (Nucleopore) 
using a mini extruder device from Avestin and Hamilton syringes. The resulting liposome 
solutions were stored at 4C until further use. The lipid vesicles were usually stable for at 
least one week under these conditions, but they were usually used within 2 days of 
preparations at most (Melo et al. 2013). 
2.3.2. PREPARATION OF CALCITONIN SAMPLES 
The interaction of both unlabeled and HL488-labeled calcitonins with POPC LUVs 
containing a variable mol% of anionic phospholipid, POPS, were studied by taking 
advantage of their intrinsic or extrinsic fluorescence properties, respectively. Briefly, a 
fixed amount of peptide was added to an increasing concentration of liposomes (usually 
within the concentration range 0 - 3mM) in HEPES-KOH buffer, pH 7.4. UV-Vis absorption, 
steady-state and time-resolved fluorescence measurements were then performed for each 
sample using the conditions described below.      
Each peptide containing sample was prepared independently, usually just before the 
spectroscopic measurements, using one of two methods: (method A) direct injection of the 
required volume from a calcitonin stock solution prepared in HFIP to HEPES-KOH buffer, 
pH 7.4 buffer already containing the anionic lipid vesicles. The final concentration of the 
solvent was always kept <1% (vol/vol); (method B) Evaporation of the organic solvent 
(HFIP) from the required volume of the peptide stock solution using a nitrogen flow and 
subsequent re-suspension of the peptide film in HEPES-KOH buffer, pH 7.4. The lipid 
vesicles were then added to the peptide solution. In each case, the stock solution of the 
peptide in HFIP was allowed to thermally stabilize at RT for 10 min and then sonicated for 
approximately 1 min in a bath sonicator prior to its use.  
2.3.3. DETERMINATION OF PARTITION COEFIFICIENTS  
The partition coefficient of the peptide under study was determined by monitoring the 
changes in its steady-state fluorescence anisotropy in both the intrinsic and extrinsic 
fluorescence partition studies performed with the unlabeled and fluorescently labeled 
calcitonins, respectively.  
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On thermodynamic grounds, the membrane bound peptide molar fraction, 𝑥𝑙 , can be 
written as function of its partition coefficient between the lipid and aqueous phases, 𝐾𝑝, 
where [L] and [W] are the phospholipid and water concentration, respectively (Castanho 
& Prieto 1992; Poveda et al. 2003; Santos et al. 2003): 
 
𝑥𝑙 =
𝐾𝑝[𝐿]
[𝑊] + 𝐾𝑝[𝐿]
 [2.2] 
This function is obtained considering the mass balance of the system and the simplified 
formulation of the partition coefficient, 𝐾𝑝, given by equation 2.3, where 𝑛
𝑤 and 𝑛𝑙 are the 
number of moles of water and lipid, respectively, and the 𝑛𝑝
𝑖  are the number of moles of 
the peptide in each phase (i=w for aqueous phase and i=l for lipid phase): 
 
𝐾𝑝 =
𝑛𝑝
𝑙
𝑛𝑙
×
𝑛𝑤
𝑛𝑝
𝑤  [2.3] 
In addition, considering that the steady-state fluorescence anisotropy is an additive 
parameter (Valeur 2002; Lakowicz 2006), the fluorescence anisotropy of a peptide in the 
presence of liposomes can be written as: 
 
< 𝑟 >= ∑ 𝑓𝑖𝑟𝑖 = 𝑓𝑤𝑟𝑤 + 𝑓𝑙𝑟𝑙 =
𝜀𝑤𝛷𝑤𝑥𝑤
𝜀𝑤𝛷𝑤𝑥𝑤 + 𝜀𝑙𝛷𝑙𝑥𝑙  
 𝑟𝑤 +
𝜀𝑙𝛷𝑙𝑥𝑙
𝜀𝑤𝛷𝑤𝑥𝑤 + 𝜀𝑙𝛷𝑙𝑥𝑙
 𝑟𝑙  [2.4] 
where 𝑓𝑖  is the fraction of light emitted by the peptide and 𝑥𝑖  is its molar fraction in the 
aqueous (i= w) and lipid phase(i= l), respectively.  𝑖  , 𝑖   and 𝑟𝑖  are the molar absorption 
coefficient, the fluorescence quantum yield and the steady-state fluorescence anisotropy 
of the peptide in each phase. Taken together equations 2.2 and 2.4, the fluorescence 
anisotropy of the peptide can be described as a function of [L] by equation 2.5, where 𝑄 =
𝜀𝑙𝛷𝑙/𝜀𝑤𝛷𝑤. 
 
< 𝑟 > =  
𝑟𝑤[𝑤] + 𝐾𝑝[𝐿]𝑟𝑙𝑄
[𝑤] +  𝐾𝑝[𝐿]𝑄
 [2.5] 
Further assuming that the molar absorption coefficient of the peptide is invariant with the 
environment, the 𝑄 parameter simplifies to 𝛷𝑙/𝛷𝑤. 𝐾𝑝 as well as 𝑟𝑙 can be retrieved from a 
non-linear regression fit of equation 2.5 to the experimental steady-state fluorescence 
anisotropy data obtained for the peptide in the presence of increasing concentrations of 
phospholipid, [L]. This non-linear regression fit was made taken into account the 
accessible phospholipid concentration, which was considered half of the total lipid 
concentration (Melo et al. 2013). 
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Scatter Control in Intrinsic Fluorescence Studies 
The increase in phospholipid concentration can cause an artificial decrease in the 
fluorescence anisotropy of the peptide due to light scattering (turbidity of the lipid 
suspensions)(Eisinger & Flores 1985), particularly in intrinsic fluorescence 
measurements when low excitation wavelengths are used (λexc= 275nm). To control the 
scatter effect on these samples, an optimization of the steady-state fluorescence 
anisotropy measurements was performed, which included testing different cuvettes (with 
variable path length: 1 mm, 2 mm, 4 mm, 5 mm and 10 mm) and geometric arrangements 
(right angle and front face geometries), in order to decrease the light scattered by the 
liposome-containing samples (Figure 2.3A).  
Briefly, the same experimental design as the one used for the partition studies described 
above was employed, but now 100mol% POPC vesicles were prepared and a fixed bovine 
insulin concentration of 25μM was used instead of salmon calcitonin. Both the lipid 
vesicles and insulin have no net charge at pH=7.4, so the peptide is not expected to 
interact strongly with these zwitterionic membranes and the observed variations in its 
steady-state anisotropy can be assumed to be due the scattering effect of the liposome 
suspensions (Figure 2.3B). The relative decrease in the steady-state fluorescence 
anisotropy of insulin measured for each phospholipid concentration was therefore added 
to the respective value measured for the calcitonin-containing sample with an equivalent 
scattering contribution at the excitation wavelength used. 
 
Figure 2.3: Typical results obtained for the variation of (A) the pseudo-absorbance at 275 nm and 
(B) the steady-state fluorescence anisotropy of 25M insulin with the total phospholipid 
concentration in solution using POPC LUVs. The spectroscopic measurements were performed 
using 5x5mm quartz cuvettes at RT. 
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2.3.4. PEPTIDE-INDUCED LIPOSSOME AGGREGATION  
The possibility of peptide-induced aggregation of liposomes was evaluated from the 
changes in 90 light scattering, which putatively follows the increase in turbidity upon 
addition of the unlabeled or HL488-labeled peptide to the lipid vesicles due to cross-
bridging of the liposomes. Right-angle light scattering was evaluated in a 
spectrofluorometer from a 10s emission time trace with the excitation and emission 
wavelengths set at 650 nm (2 and 4nm bandwidths for excitation and emission, 
respectively), a spectral region where there is no HL488 absorption or emission. 
2.4. UV-VIS SPECTROSCOPY  
UV-Vis absorption spectra were measured at RT using a double-beam V-660 
spectrophotometer from Jasco Analytical Instruments. Typically, the absorption spectra of 
the samples were taken from 250nm to 700nm in 5x5mm path length quartz cuvettes 
using a bandwidth and a sampling interval of 1 nm, after an air versus air baseline. 
Occasionally, black 10x4mm path length quartz cuvettes were also for determining the 
peptide concentration in buffer. 
2.4.1. BASELINE CORRECTIONS  
In a set of measurements performed with a fixed peptide concentration in the presence of 
increasing phospholipid concentrations (partition studies), it was observed that the 
control absorption spectrum obtained for each sample (liposomes at a given 
concentration) did not exactly overlap the spectrum obtained for the respective peptide 
containing sample (liposomes + peptide), probably due to difficulties in positioning the 
cuvettes in the spectrophotometer in a reproducible way (Fig.2.4A). For this reason, a 
“pseudo-background” spectrum was obtained for each sample by performing a non-linear 
regression fitting of an empirical power law (equation 2.6) to its absorption spectra 
(liposomes + peptide) in the wavelength range where significant absorption does not 
occur: 
 𝐴𝑏𝑠 = 𝑏 + 𝜆−𝑘   [2.6] 
The wavelength interval(s) used for the unlabeled calcitonins was 450-800nm and for the 
HL488-labeled peptides 350-400nm & 550-700nm, respectively.  
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The empirical fitting parameters  obtained, b and k, were used to extrapolate equation 2.6 
to all wavelength values, resulting in an “pseudo-background” baseline that was 
subtracted from each sample, producing a corrected absorption spectrum that could be 
inter-compared (Figure 2.4B). This correction allowed the decomposition of each 
spectrum in its absorption and turbidity spectra (adapted from Castanho et al. 1997).  
 
Figure 2.4: (A) Absorption spectra obtained for 250M POPC LUVs containing 20mol% of POPS in 
the absence (blue curve) and in the presence of 3.4M sCT-HL488 (red curve). (B) Corrected 
absorption spectrum (green curve) resulting from subtracting the extrapolated “pseudo-
background” baseline (blue curve) from the sample absorption spectrum (red curve). See the text 
for more details. 
The adequacy of this data treatment was evaluated by confirming that the relative 
absorption at the maximum absorption wavelength, Absmax, obtained for each corrected 
absorption spectrum was essentially independent of the phospholipid concentration used 
in each assay (Figure 2.5A) and that the average Absmax calculated for three different 
peptide concentrations used obeyed the Beer-Lambert law (Figure 2.5B). 
 
2.5. FLUORESCENCE SPECTROSCOPY  
2.5.1. STEADY-STATE FLUORESCENCE MEASUREMENTS 
Intrinsic fluorescence studies: Intrinsic fluorescence measurements for both unlabeled 
calcitonin peptides (sCT and hCT) were performed in a HORIBA Jobin Yvon Fluorolog-3-
21 spectrofluorometer (New Jersey, USA) since the quantum yield of their tyrosine 
residues was very low and this was the most sensitive apparatus in the laboratory. This 
spectrofluorometer has double excitation and single emission monochromators (IHR 320, 
New Jersey, USA), respectively, and is fitted with automated rotating Glan-Thompson 
polarizers. 
B A  
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The light source was a 450-Watt Xe lamp and the reference was a silicon diode. This 
spectrofluorometer contains a R928P photomultiplier tube detector which provides 
sensitive spectral characterization in the UV through the visible range of wavelengths. In 
addition, this apparatus is equipped with a FI-3751 thermoelectric temperature controller 
(Wavelength Electronics) which allows programming the temperature for data 
acquisition.  
 
Figure 2.5: (A) Representation of the relative absorption at the maximum absorption wavelength, 
Absmax, obtained for each peptide corrected absorption spectrum as a function of total 
phospholipid concentration present in the sample. The sCT-HL488 concentrations used were 0.2 
M (green, purple and orange dots for POPC:POPS 90:10, 80:20 and 70:30 LUVs, respectively), 1.0 
M (red triangles for POPC:POPS 80:20 LUVs) and 3.4 M (blue squares for POPC:POPS 80:20 
LUVs). The dashed lines represent the mean Absmax value obtained for each peptide concentration. 
(B) The average Absmax obtained obeys the Beer-Lambert law. The dashed line represents the 
predicted value for each peptide concentration assuming that its molar absorption coefficient is 
independent of the lipid concentration used (= 70 000 M-1 cm-1 and a path length of 5 mm). 
Typically, an excitation wavelength of 275 nm as well as an emission of 300 nm was used 
for tyrosine intrinsic fluorescence measurements, with excitation and emission 
bandwidths of 3 and 6 nm, respectively. Steady-state fluorescence anisotropy 
measurements were taken with excitation and emission wavelengths of 275 and 300 nm, 
respectively, using excitation and emission bandwidths of 7 nm (Table 2.3).  
Extrinsic fluorescence studies: Fluorescence measurements for the free dye and both N-
terminally HL488-labeled calcitonins (sCT-HL488 and hCT-HL488, respectively) were 
performed on a SLM-AMINCO 8100 spectrofluorometer from SLM Instruments Inc. with 
double excitation and emission monochromators. This apparatus, which also contains 
automated rotating Glan-Thompson polarizers, was operated in photon-counting mode. 
The reference was a Rhodamine B quantum counter solution.  
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The sample temperature was controlled with a water circulating bath from Julabo (model 
F25). Typically, the emission and excitation spectra were measured using λexc=480 nm 
and λem=525 nm, respectively, through an excitation and emission bandwidths of 2 and 8 
nm, respectively. Steady-state fluorescence anisotropy measurements were taken with 
excitation and emission wavelengths of 335 nm/525 nm or 480 nm/525 nm, respectively, 
using excitation and emission bands of 4 and 8 nm (Table 2.3). 
For both spectrofluorimeters, the measurements were usually performed using 5x5mm 
width quartz cuvettes at RT in right-angle geometry (unless mentioned exceptions) and 
background intensities were always taken into account and subtracted from the measured 
sample intensities. 
Determination of Spectral Shifts  
The shift in the fluorescence emission spectra were determined by calculating the 
intensity average emission wavelength, < 𝜆 >, that is given by the simple calculation of 
the centre of mass (CM) of the emission spectrum (equation 2.7), where 𝐼𝑖  is the intensity 
value for each wavelength, 𝜆𝑖  (Royer et al. 1993). Mathematically, the CM is the point that 
divides the area of the spectrum in two parts of equal area. Concerning to the emission 
energy, the CM is the medium point of the spectrum. 
 
< 𝜆 > =  ∑(𝐼𝑖𝜆𝑖)/ ∑(𝐼𝑖)
𝑁
𝑖=1
𝑁
𝑖=1
  [2.7] 
This method is more reliable than just the maximum peak intensity since is less prone to 
instrumental noise than is the peak maximum because it is an integral measurement, and 
also a more sensitive value because it arises from a calculation involving the entire 
spectrum, and thus it reflects changes in the shape of the spectrum as well as in position. 
Steady-State Fluorescence Anisotropy 
The steady-state fluorescence anisotropy, <r >, was obtained by measuring the vertically 
(parallel, IVV) and horizontally (perpendicular, IVH) polarized components of the 
fluorescence emission with the excitation polarized vertically, as defined by: 
 
< 𝑟 >=
𝐼VV − 𝐺𝐼VH
𝐼VV + 2𝐺𝐼VH
 [2.8] 
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The G factor is the ratio of the sensitivities of the detection system for vertically and 
horizontally polarized light, and is defined as G=IHV/IHH. This parameter corrects for the 
bias in the transmissivity between vertically and horizontally polarized components of the 
emission introduced by the detection system (Lakowicz 2006). Background intensities 
were always taken into account and subtracted from the measured samples intensities. 
Fluorescence Quantum Yield Measurements 
The efficiency of the fluorescence process was evaluated by measuring the fluorescence 
quantum yield of the fluorophore, ΦF, using a relative method (Valeur 2002). This 
parameter is related to that of a standard, ΦFS, by equation 2.9, where Absi is the 
absorption of a diluted solution of each compound at the excitation wavelength, Fi is the 
area under the corrected emission curve and ni is the refractive index of the solvent used. 
The subscripts i= S and i= X refer to the standard and to the unknown species, 
respectively.  
 ΦF
ΦFS
= (
1 − 10−𝐴𝑏𝑠S
1 − 10−𝐴𝑏𝑠X
) (
𝐹X
𝐹S
) (
𝑛X
2
𝑛S
2) [2.9] 
It is always advantageous to choose a standard with absorption and emission bands close 
to those of the unknown and to excite both compounds at the same wavelength (Fery-
Forgues & Lavabre 1999). For this reason N-acetyl-L-tyrosinamide (NAYA) was chosen as 
a standard in the determination of the fluorescence quantum yield of the unlabeled 
peptides (ΦFS =  0.049 in (Noronha et al. 2007)) and fluorescein was used as a standard 
for the fluorescently labeled peptides (ΦFS = 0.95 ± 0.03 in NaOH (Lakowicz 2006)). The 
measurements were performed at 25C. 
2.5.2. TIME-RESOLVED FLUORESCENCE MEASUREMENTS 
Time-resolved fluorescence intensity measurements were performed by the time-
correlated single-photon timing technique (TCSPT). Briefly, the time between each laser 
excitation pulse and the detected photon is measured in this technique, producing a 
photon distribution histogram that represents the number of photons detected within the 
time interval, describing the fluorescence intensity decay (Lakowicz 2006). The 
experimental conditions used were adjusted so that less than one photon was detected per 
laser pulse. The samples were excited by frequency doubling of a rhodamine 6G or DCM 
dye laser for intrinsic fluorescence measurements (λexc=280 nm) and extrinsic 
fluorescence measurements (λexc=335 nm), respectively. 
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Fluorescence intensity decays, I(t), were measured with an emission polarizer set at the 
magic angle (54.7O) relative to the vertically polarized excitation beam with excitation 
wavelength of 280 nm or 335 nm for the unlabeled and fluorescently labeled peptides, 
respectively. This condition was used to avoid the effects of rotational diffusion and/or 
anisotropy on the intensity decay (Lakowicz 2006). The fluorescence was detected at 300 
nm (for the unlabeled peptides) or 525 nm (for the labeled peptide) using a Jobin-Yvon 
HR320 monochromator in combination with a cutoff filter to avoid interference from 
Rayleigh-scattered light and a Hamamatsu R-2809U microchannel plate photomultiplier 
(Table 2.3) The instrument response function, IRF(t), was recorded as excitation light 
scattered by a Ludox solution (silica, colloidal water solution from Aldrich).  
The data were collected in a multichannel analyzer with a time window of 1024 channels, 
at typically 19.5 picoseconds per channel, for intrinsic fluorescence decays, and 24.4 
picoseconds per channel for extrinsic fluorescence decays. Generally up to 50 000 and 20 
000 counts in the peak channel of the IRF and decay curves, respectively, were collected. 
In some cases, the two components of the fluorescence, polarized parallel, IVV(t) and 
perpendicular, IVH(t) to the plane of polarization of the excitation beam, were recorded 
sequentially by automatically alternating the orientation of the emission polarizer every  
30 or 60 s.  
 
Table 2.3: Summary of the excitation and emission wavelengths typically used in the steady-state 
and time-resolved fluorescence measurements performed with the free dye (HL488), unlabeled 
peptides (sCT and hCT) and fluorescently labeled peptides (sCT-HL488 and hCT-HL488), 
respectively. 
 
Samples 
 Steady-State Fluorescence 
Emission  Spectra 
aa 
Steady-State 
Fluorescence Anisotropy 
aa 
Time-resolved 
measurements 
 𝜆exc 
(nm) 
𝜆em 
(nm) 
  
𝜆exc 
(nm) 
𝜆em 
(nm) 
  
𝜆exc 
(nm) 
𝜆em 
(nm) 
sCT  275 275-380   275 300   280 300 
hCT  275 275-380   275 300   280 300 
HL488  480 485-680   480 525   335 525 
sCT-HL488  480 485-680   480 525   335 525 
hCT-
HL488 
 480 485-680   480 525   335 525 
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Data Analysis for Intensity Decays 
The fluorescence intensity decay curves, 𝐼(𝑡), were described by a sum of discrete 
exponential terms, as defined by equation 2.10, where αi and τi are, respectively, the 
normalized amplitude and  the decay time of the ith decay component of the fluorescence: 
 
𝐼(𝑡) =  ∑  𝛼i exp(−𝑡/τi)
𝑛
𝑖=1
 [2.10] 
The decay parameters were obtained by an iterative convolution of the empirical function 
above with the instrumental response function, 𝐼𝑅𝐹(𝑡): 
 𝐼𝑐𝑎𝑙𝑐(𝑡) =  𝐼(𝑡)𝐼𝑅𝐹(𝑡) [2.11] 
and fitting 𝐼𝑐𝑎𝑙𝑐(𝑡) to the experimental data 𝐼(𝑡) using a non-linear least squares 
regression method. It was helpful to calculate the amplitude-weighted lifetime of the 
decay, <>1, which is proportional to the area under the decay curve and consequently to 
the fluorescence quantum yield of the fluorophore in the absence of static quenching 
(equation 2.12):  
 
< 𝜏 >1= ∑ 𝛼𝑖𝜏𝑖
𝑛
𝑖
 [2.12] 
and the intensity-weighted mean fluorescence lifetime, <>2:  
< 𝜏 >2= ∫ 𝐼(𝑡)𝑑𝑡 
∞
0
=
∑ αiτi2 
∑ αiτi
= ∑ 𝑓𝑖𝜏𝑖
𝑛
𝑖
 [2.13] 
The values obtained for αi and τi can also be used to calculate the fractional contribution, ƒi, 
of each decay time to the steady state Intensity (equation 2.13). 
Data Analysis for Anisotropy Decays 
The fluorescence anisotropy decay curves, 𝑟(𝑡), were also described by a sum of discrete 
exponential terms (equation 2.14), where βi and φi are the normalized amplitude and the 
rotational correlation time of the ith decay component of the anisotropy, and r is the 
residual anisotropy, respectively: 
 𝑟(𝑡) = ∑ 𝛽𝑖exp (−𝑡/𝜑𝑖) 
𝑛
𝑖=1
+  𝑟∞ [2.14] 
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When the anisotropy value does not decay to zero at long times, it means that the angular 
range of the rotational motion is limited, caused by a barrier that prevents rotational 
diffusion of the fluorophore beyond a certain angle. The r∞ parameter corresponds to the 
residual anisotropy, containing information about that restriction of the depolarizing 
process. Rotational correlation times, φi, are determined by the size, shape and flexibility 
of the macromolecules, resulting in anisotropies that are sensitive to the micro 
environment and interactions with other molecules.  
The time-resolved anisotropy decays were globally analyzed using a two-step procedure. 
When a fluorophore is excited, the total intensity decay at the magic angle can be 
calculated using equation 2.15, which eliminates the contribution of  𝑟(𝑡) to the total 
decay:  
 𝐼(𝑡) = 𝐼𝑉𝑉(𝑡) + 2𝐼𝑉𝐻(𝑡) [2.15] 
Therefore, the fluorescence intensity decay parameters were first obtained by iterative 
convolution of equation 2.10 with the 𝐼𝑅𝐹(𝑡) and fitting to the experimental data, as 
calculated above using a nonlinear least-squares regression method. Then, simultaneous 
iterative convolution of  𝐼𝑉𝑉(𝑡) (equation 2.16) and 𝐼𝑉𝐻(𝑡) (equation 2.17) with the 
𝐼𝑅𝐹(𝑡) and globally fitting to the experimental parallel and perpendicular polarized 
components of the fluorescence intensity were performed in order to obtain the 
anisotropy decay parameters:  
 
𝐼𝑉𝑉(𝑡) =
1
3
𝐼(𝑡)[1 + 2 𝑟(𝑡)] [2.16] 
 
𝐼𝑉𝐻(𝑡) =
1
3
𝐼(𝑡)[1 − 𝑟(𝑡)] [2.17] 
These polarized intensity decays were then used to calculate the time-dependent 
anisotropy as given by equation 2.18, after fixing in this analysis the fluorescence intensity 
decay parameters obtained in the first step: 
 
𝑟(𝑡) =
𝐼𝑉𝑉(𝑡) − 𝐼𝑉𝐻(𝑡)
𝐼𝑉𝑉(𝑡) + 2𝐼𝑉𝐻(𝑡)
 [2.18] 
The experimental steady-state fluorescence anisotropy, <r>, was sometimes used as a 
constraint in the global analysis of the data, by introducing a G factor in this analysis that is 
related to the experimental data according to equation 2.19. 
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This parameter accounts for experimental artifacts such as photobleaching and laser 
fluctuations during the time-resolved fluorescence measurements. The instrumental G 
factor for our setup system is expected to be one because the polarized fluorescence light 
components were depolarized before the entrance slit of the monochromator. 
Accordingly, and as expected, this factor varied only slightly between 0.95 and 1.05. 
To further confirm the adequacy of the time-resolved anisotropy fit, the expected steady-
state fluorescence anisotropy was calculated using the parameters obtained from the 
time-resolved analyses using equation 2.20, which relates the average of the anisotropy 
decay with the steady state value, yielding highly consistent results (data not shown 
trough the work). 
 
< 𝑟 >𝑐𝑎𝑙𝑐=
∫ 𝐼(𝑡)𝑟(𝑡)𝑑𝑡
∞
0
∫ 𝐼(𝑡)𝑑𝑡
∞
0
 [2.20] 
The fluorescence intensity and anisotropy decays obtained were analyzed using the TRFA 
Data Processing Package Version 1.4 of the Scientific Software Technologies Center 
(Belarusian State University). To evaluate the goodness of the fits, the reduced χ2 
parameter was used. We assumed that the empirical fitting models used were adequate 
when the reduced χ2  was lower than 1.3 and a random distribution of weighted residuals 
and autocorrelation plots were obtained (Lakowicz 2006). 
Time-Resolved Emission Spectra 
Evolution of fluorescence spectra during the lifetime of the excited state can provide 
interesting information about the microenvironment around a fluorophore. A typical 
example is the solvent relaxation around an excited-state compound whose dipole 
moment is higher in the excited state than in the ground state (Valeur 2002; Lakowicz 
2006). When a fluorophore is excited to an unrelaxed state, the solvent reorients around 
the excited-state dipole moment and it will relax to a new equilibrium with the 
surrounding molecules since the excited molecules have a higher dipole moment than 
those in the ground-state. At the moment of excitation all the molecules are assumed to be 
in the unrelaxed state and no molecules are in the totally relaxed state until some 
relaxation has occurred. The fluorescence intensity decays will therefore depend on the 
observation wavelength because of the time needed for the unrelaxed state to become 
totally relaxed or reach some intermediate state (Figure 2.6). 
 
𝐺 =
1−< 𝑟 >
1 + 2 < 𝑟 >
.
∫ 𝐼𝑉𝑉(𝑡)𝑑𝑡
∞
0
∫ 𝐼𝑉𝐻(𝑡)𝑑𝑡
∞
0
 [2.19] 
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The solvent relaxation results in a gradual red-shift of the fluorescence spectrum. The 
fluorescence intensity decay measured on the short-wavelength side of the total emission 
shows a more rapid decay than the decay of the total emission because the short-
wavelength emission of the fluorophore is decaying by both emission and relaxation 
 
Figure 2.6: Schematic illustration of the solvation dynamics showing the orientational motions 
along the solvation coordinate. As the solvation relaxation proceeds the energy of the solute 
decreases giving rise to a red-shift of the fluorescence spectrum until the completely relaxed state 
is reached. (Adpated from (Pal et al. 2002). 
On the long-wavelength side of the emission, the emission is essentially occurring from the 
relaxed species in solution and a rise in the intensity at long wavelengths was observed, 
representing the formation of the relaxed state. This rise is associated with the negative 
amplitudes obtained in the intensity decay analysis. In the course of time the fluorophore 
will relax due to solvent reorientation and the excited state energy slides towards the 
equilibrium state of the relaxed species, then the emission occurs at all positions along the 
reaction coordinate (Lakowicz, 2008).  
The time-resolved emission spectra (TRES) are basically the emission spectra of the 
compound at a given time after the excitation pulse. In order to determine TRES, 
fluorescence intensity decays at several emission wavelengths, I(λ,t), are measured, 
together with the corrected steady-state fluorescence emission spectra, F(λ).  
 
𝐼(𝜆, 𝑡) = ∑ 𝛼𝑖(𝜆) 𝑒𝑥𝑝[−𝑡/𝜏𝑖(𝜆)  ]
𝑛
𝑖=1
 [2.21] 
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This enables the calculation of the TRES given by F(λ,t) using equation 2.22 (Easter et al. 
1976; Berberan-Santos et al. 1991).   
 
𝐹(𝜆, 𝑡) =  
𝐹(𝜆, 𝑡)𝐼(𝜆, 𝑡)
∫ 𝐼(𝜆, 𝑡)𝑑𝑡
∞
0
   [2.22] 
The intensity decays were analysed in terms of a multi-exponential model (equation 2.10) 
and no molecular significance is assigned to the intensity decay parameters for each 
emission wavelength.  
2.5.3. FLUORESCENCE TIME COURSE MEASUREMENTS 
The kinetics of interaction between the HL488-labeled peptides and the lipid vesicles 
prepared with variable lipid composition were measured using a POLARstar OPTIMA 
micro plate reader. Peptide containing samples were prepared independently in 
Eppendorf tubes according to methods (A) or (B) described above (section 2.3.2) and 
applied to a 96-well Greiner Bio-One non-binding black microplate. Both the time course 
of the steady-state fluorescence intensity and anisotropy were measured for each sample 
using excitation and emission filters centred at 485 nm and 520nm, respectively, with a 10 
nm bandwidth. Each kinetics was monitored during 16 hours at 25C, with measurements 
taken at every 4 min with a 30 seconds shaking cycle before each point. 
2.6. DYNAMIC LIGHT SCATTERING AND ZETA POTENTIAL  
Dynamic Light Scattering 
The Dynamic Light Scattering (DLS) technique measures the Brownian motion of the 
particles and relates it to their size/shape (Figure 2.7B).  For monodisperse spherical 
particles in solution, the fluctuations in intensity of scattered light at a single angle are 
detected and analyzed with an autocorrelation function (equation 2.23) according to the 
Doppler effect (Murphy 1997; Domingues et al. 2008) where D is translational diffusion 
coefficient of the particle, τ is the decay time and q is the scattering vector, which is a 
function of the solvent refractive index, the scatter angle and the wavelength of the 
incident beam. 
 𝑔(𝜏) = exp (−𝐷𝑞2𝜏) [2.23] 
Thus, as the frequency shift through variations on the scatter pattern, the diffusion 
coefficient of the particle is obtained from the decay rate of the intensity.  
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The measured quantity is then the translational diffusion coefficient of the particle which 
is used to calculate the hydrodynamic radius, 𝑅ℎ using the Stokes-Einstein equation 
(equation 2.24) where kB is the Boltzmann’s constant and η the viscosity of the medium at 
the absolute temperature T .  
 
𝐷 =
𝑘B𝑇
6𝜋𝜂𝑅ℎ
 [2.24] 
Electric Zeta potential  
The electric potential Zeta, ζ, gives an indication of the potential stability of the colloidal 
system (Figure 2.7A). If all the particles in suspension have a large negative or positive 
zeta potential they will tend to repel each other and there will be no tendency for the 
particles to come together. Otherwise (low zeta potential values) they will tend to 
generate an unstable suspension and the particles will likely aggregate (Freire et al. 2011; 
Domingues et al. 2008; Faustino et al. 2014) (see Figure 2.7A for details). 
ζ-potential is calculated by measuring the electrophoretic mobility of the particles in 
solution, when an oscillating electric field is applied. The electrophoretic mobility can be 
calculated by laser Doppler velocimetry in Zeta-sizer devices, in which particle velocity is 
related to the frequency measured by intensity fluctuation of the scattered light. The 
electrophoresis mobility, U, is related to the ζ-potential by Henry’s equation 2.25 where ε 
is the dielectric constant and f(κa) is the Henry’s function, which is related with the 
“thickness” of the electrical double layer: 
𝑈 =
2𝜀ζ𝑓(ka)
3𝜂
 [2.25] 
Henry’s function is equal to 1.5 when working in an aqueous medium with moderate ionic 
strength (Smoluchowski approximation).  
Using DLS and Zeta-Potential to characterize LUVs 
Large unilamellar vesicles were extruded through 100 nm pore polycarbonate filters as 
previously described and typically used immediately after preparation. The average size of 
POPC:POPS vesicles was investigated as a function of mol%POPS. In order to characterize 
the phospholipid vesicles, both ζ-potential and DLS measurements were performed using 
a Malvern Zetasizer Nano ZS Apparatus (Malvern,UK) with a backscattering detection at a 
constant 173 scattering angle. The apparatus was equipped with a He–Ne laser (λ = 
632.8 nm). Aliquots of 400 M POPC LUVs containing 0, 10, 20 or 30 mol% POPS were 
prepared in triplicate in Eppendorf tubes using filtered HEPES-KOH buffer.  
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For DLS measurements, each sample was filtered into a DLS cuvette and the instrument 
performed 3 scans with 10 runs each, with an initial equilibration time of 2 min at 25C.  
The scattering intensity data were processed using the software of the instrument to 
obtain the size distribution of each sample. Malvern’s software analyses the acquired 
correlogram and the hydrodynamic diameters of the particles were estimated from the 
autocorrelation function using the method of cumulants (Frisken 2001). 
For ζ-potential measurements, each sample was filtered into a zetasizer folded capillary 
cells DTS 1060 (Malvern,UK) and the instrument performed 10 scans with a maximum of 
100 runs (the scan stopped when the measurement had enough statistical significance) 
with an initial equilibration time of 2 min at 25C.  Values of the viscosity and refractive 
index values were set at 0.8872 cP and 1.330, respectively. Data analysis was processed 
using the instrumental Malvern’s DTS software to obtain the mean zeta-potential value. 
 
Figure 2.7: (A) Charge particles in solution attract ions to their surface, forming two layers: an 
internal layer called Stern Layer, where the counter ions are strongly attached to the particle, and 
an outside layer, where the attachment to the particle is weak and ions diffuse more freely. In the 
presence of an electrical field, the particle moves and the ions within the double layer move with it, 
but the ions on the diffuse boundary do not move concomitantly to the scattering particle. The 
electric potential that exists at this boundary is called the ζ-potential. (B) The speed at which the 
particles are diffusing due the Brownian motion is measured by quantification of the fluctuations in 
the scattered light by an incident laser as a function of time. In a solution with millions of particles 
the detected signal has a pattern that varies over time due to Brownian motion of the particles. The 
information about the particle size is obtained by a correlation function that measures the degree of 
similarity of intensity patterns over time. [Adapted from Malvern’s Zetasizer User Manual consulted 
in July 2014] 
 
A B 
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Table 2.4: Results obtained for the zeta potential, ζ, and liposome diameter (from intensity peak 
distribution) for POPC LUVs prepared with a variable mol% of POPS by extrusion in Hepes-KOH 
20mM, pH 7.4 buffer. The values are presented as mean ± standard deviation for n=3 independent 
sample measurements. 
 
 
 
 
As expected, the average lipid vesicle diameter, , was found to be essentially independent 
of the mol% of POPS used to prepare the liposomes (= (107  3 ) nm, n= 4 ), whereas the 
ζ-potential progressively decreased upon augmenting the anionic phospholipid content of 
the lipid mixtures used to prepare the liposomes, reflecting an increase in their anionic net 
surface charge density (Table 2.4). 
 
mol% POPS 
ζ-potential 
(mV) 
 
Diameter 
(nm) 
0 - 6.1 ± 2.7 110.5 ± 0.6 
10 - 13.1 ± 0.9 107.9 ± 0.8 
20 - 24.4 ± 1.7 103.7 ± 2.1 
30 - 43.9 ± 1.9 106.6 ± 0.45 
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3. RESULTS AND DISCUSSION 
3.1. INTRINSIC FLUORESCENCE STUDIES 
In the first part of this work, the intrinsic fluorescence properties of both salmon (sCT) 
and human (hCT) calcitonin were evaluated as a possible tool to gain insights on the 
interaction and insertion of these peptides into the anionic lipid membranes.  In fact, both 
CT variants used in this work are intrinsically fluorescent due to the presence of a single 
tyrosine and no tryptophan residues in each sequence (Y22 and Y12 in sCT and hCT, 
respectively, see Figure 2.1 in Chapter II). Typically, the intrinsic fluorescence of tyrosine 
has been less used than that of tryptophan residues to explore the interaction of peptides 
and proteins with lipid membranes, mainly because of the low quantum yield, low 
extinction coefficient and short absorption wavelength, as well as its low sensitivity to 
changes in the surrounding environment (Poveda et al. 2003). However, despite these 
apparent disadvantages, tyrosine shows a high intrinsic anisotropy and fluorescence 
lifetime optimal to characterize nanosecond and subnanosecond motions in peptides and 
proteins and therefore, it could be a useful probe to study structural and dynamics 
changes in both CT variants in solution and upon their interaction with membranes 
(Rolinski et al. 2010; Amaro et al. 2011). Moreover, this methodology offers the additional 
advantage that no extrinsic fluorophores are covalently linked to the polypeptide 
sequences, which have the potential to perturb their native structure in solution and affect 
the aggregation kinetics 
3.1.1. HUMAN AND SALMON CALCITONINS IN AQUEOUS SOLUTION 
The photophysical and dynamic proprieties of both CT variants were first analysed in 
buffer solution. For this, each sample was freshly prepared independently by direct 
injection of the required volume from a calcitonin stock solution in HFIP into the aqueous 
buffer solution (Method A) and characterized using both steady-state and time-resolved 
fluorescence measurements. Both the wavelengths of maxima excitation and emission 
fluorescence intensity of sCT and hCT were similar to the ones obtained for free NAYA in 
solution as expected (Figure 3.1A and Table 3.1), since NAYA mimics a tyrosine residue 
establishing two peptide bonds. However, the fluorescence quantum yields measured for 
sCT and hCT were Φ= 0.012 ± 0.009 and Φ=0.013 ± 0.010, respectively, much lower than 
the characteristic value presented by NAYA in aqueous solution (Table 3.1).  
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Table 3.1: Maximum absorption, excitation and emission wavelengths ( 𝐚𝐛𝐬
𝐦𝐚𝐱,  𝐞𝐱𝐜
𝐦𝐚𝐱 and 𝐞𝐦
𝐦𝐚𝐱, 
respectively), Quantum yield (Φ) and steady-state fluorescence anisotropy, <r> (𝐞𝐱𝐜=275 nm; 
𝐞𝐦=300 nm) of NAYA, sCT and hCT in HEPES-KOH, pH 7.4 buffer. The anisotropy values are 
presented as mean ± standard deviation for a set of ten measurements. Concentrations of 10μM 
were used for all samples.  
 
The steady-state fluorescence anisotropies of sCT and hCT were <r>= 0.060±0.04 and 
<r>= 0.070±0.03, respectively (Table 3.1). The time-resolved decays of both peptides in 
aqueous solution were best fitted to three exponential functions (Table 3.2). The three 
exponential decay reflects the existence of ground-state rotamers sensing different 
chemical environments (Poveda et al. 2003; Amaro et al. 2011). The slightly different 
fluorescence decays obtained for the two peptides must reflect differences in local 
interactions sensed by the rotamers due to the changes in their polypeptide chain 
sequences and position of the tyrosine residue in the primary structure (see Figure 3.1B).  
 
Figure 3.1: (A) Fluorescence excitation (dashed lines, λem=300 nm) and emission spectra (solid 
lines, λexc=275 nm,) for 10μM NAYA (red) and sCT (blue) in HEPES-KOH (pH 7.4) buffer (B) 
Ilustration of the tyrosine residue structure showing the possible rotation aound Cα-Cβ and the 
possible positions of the phenol group. [Adapted from (Amaro et al. 2011)] 
 
 
Sample  
λ 
abs
max
 
(nm) 
λ 
exc
max
 
(nm) 
λ 
em
max
 
(nm) 
Φ <r> 
NAYA  275 276 303 0.049 ± 0.007 0.005 ± 0.005 
sCT   274 275 304 0.012 ± 0.009 0.060 ± 0.004 
hCT   275 275 305 0.013 ± 0.010 0.070 ± 0.003 
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According to literature, tyrosine and NAYA display a bi-exponential decay and 
proteins/peptides with a single tyrosine residue typical display two or more decay times 
(Lakowicz 2006; Rolinski et al. 2010; Amaro et al. 2011) in agreement with our results.  
When the side chain (the phenol group) of NAYA is exposed to different environments can 
adopt various conformational states (rotational isomers) which interchange slowly on the 
nanosecond scale, producing a multi-exponential decay (Figure 3.1B), since each of the 
excited state of the rotamers has its own decay with its specific lifetime. In agreement with 
this, the changes in the tyrosine surroundings created by the polipeptidic chain dynamics 
result in different environments for each rotameric conformation of tyrosine side chain, 
producing different types of rotamers and creating a more complex decay (Chamberlain & 
Bowie 2004; Amaro et al. 2011). 
 
Table 3.2: Fluorescence intensity decay parameters obtained for 10 μM NAYA, sCT and hCT in 
HEPES-KOH (pH 7.4) buffer. The pre-exponential factors obtained for each lifetime component, τi, 
were normalized so that ∑αi=1. <τ>1 and <τ>2 are the amplitude-weighted and intensity-
weighted mean fluorescence lifetimes (Equation 2.12 and 2.13), respectively. The decays were 
performed using 𝐞𝐱𝐜=280 nm and 𝐞𝐦=300 nm. 
 
3.1.2. INTERACTION OF CALCITONIN WITH ANIONIC LIPID VESICLES 
The interaction of 10μM sCT with POPC:POPS 80:20 LUVs was first studied using steady-
state fluorescence measurements. Each sample was prepared independently and freshly 
before the assay by direct injection of the required volume from a calcitonin stock solution 
into the liposome suspension prepared with a variable total phospholipid concentration 
(within the range 0 to 3mM) (Method A).  
Both UV-VIS absorption and fluorescence emission spectra of sCT remained invariant 
upon addition of anionic vesicles (data not shown). On the other hand, the steady-state 
fluorescence anisotropy (Figure 3.2B) was observed to increase with the increasing 
phospholipid concentration, reflecting an adsorption of sCT on the lipid surface. The 
membrane-bound peptide was found to present a fluorescence quantum yield 1.3 times 
higer than the one obtained for the free sCT in aqueous solution (Figure 3.2A). 
Sample 
α1 
 
τ1 
(ns) 
α2 
 
τ2 
(ns) 
α3 
 
τ3 
(ns) 
<τ>1 
(ns) 
<τ>2 
(ns) 
χ2 
NAYA 0.14 0.47 0.86 1.54   1.39 1.49 0.99 
sCT 0.20 0.28 0.70 1.34 0.10 2.70 1.24 1.55 1.08 
hCT 0.31 0.28 0.53 1.08 0.16 2.28 1.03 1.44 1.27 
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After correcting the experimental steady-state anisotropy data for the scattering effects as 
described in section 2.3.3, equation 2.5 was fitted to the corrected data using a non-linear 
regression method and a 𝐾𝑝 = (5.5 ± 0.3)x10
5 of  and 𝑟𝑙 = 0.11  0.03 were obtained 
(using Q = 1.3). A similar study was performed with hCT. However, in this case, the 
corrected steady-state anisotropy values where essentially independent of the total 
phospholipid concentration used (<r>= 0.062±0.009 (n=8)), indicating that no 
interaction was established with the 20mol% POPS-containing POPC membranes in this 
case (Figure 3.2B).  
 
Figure 3.2: (A) Integrated fluorescence emission intensity and (B) steady-state anisotropy values 
for 10 M sCT (blue circles) and hCT (red triangles) as a function of phospholipid concentration 
(POPC:POPS 80:20 LUVs), with (green squares and red triangles) and without (blue circles) 
correction for the scatter effect (section 2.3.3). The green solid line represents the non-linear fit of 
equation 2.5 for Kp estimation. The red dash line represents the mean anisotropy value obtained 
for hCT: <r>=0.062±0.009 (n=8).  
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3.2. EXTRINSIC FLUORESCENCE STUDIES 
Both CT variants used in this work are intrinsically fluorescent due to the presence of a 
tyrosine residue in each peptide (Figure 2.1) as mentioned before. However, both peptides 
present low molar absorption coefficients and fluorescence quantum yields in aqueous 
solution, as discussed above in section 3.1, which renders their application in biological 
fluorescence studies problematic, particularly in the presence of highly scattering 
suspensions like liposomes.  
Therefore, full-length (residues 1-32) CT peptides prepared with both the human and 
salmon amino acid sequences were conjugated to HL488 (Figure 2.1) at their N-terminus. 
This fluorescent extrinsic probe was chosen due to its spectroscopic properties, namely 
high water solubility and insensitivity to pH from 4 to 10, together with its high 
photostability and fluorescence quantum yield (catalogue from Anaspec).  In the first part 
of this section (section 3.2.1) the spectroscopic proprieties of free HL488 dye as well as of 
both HL488-labelled calcitonin variants were first characterized in homogeneous media 
using UV-Vis absorption, steady-state and time-resolved fluorescence techniques. The 
solvents used to explore the environmental effects on HL488 photophysics were HEPES-
KOH buffers and a number of alcohols with different lengths of aliphatic chain (methanol, 
ethanol, propanol and butanol) and fluoro alchools (TFE and HFIP). These studies were 
important to provide an interpretation framework for the spectroscopic data obtained 
later when studying the interaction of both HL488-labelled calcitonin variants with 
liposomes prepared with a variable lipid composition, which are presented in the second 
part of this section (section 3.2.2). 
3.2.1. SPECTROSCOPY STUDIES IN HOMOGENEOUS MEDIUM 
3.2.1.1. Free HL488 Dye 
Absorption and Steady-State Fluorescence Properties 
Free HL488 dye presents maximum absorption and emission wavelengths of 500 and 523 
nm in both low and high ionic strength HEPES-KOH, pH 7.4 buffers, respectively (Figure 
3.3A and Table 3.3). The fluorescence quantum yield obtained for the free  HL488 dye in 
HEPES-KOH (pH 7.4) buffer using fluorescein as reference standard was Φ=0.74 ± 0.05, 
slightly less than the one described by the manufacturer for the dye in dimethylsulfoxide  
(DMSO) or dimethylformamide (DMF) (Φ=0.91), possibly due to the different solvent 
used.  
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Upon reducing the dielectric constant of the medium from ε = 80.4 (water) to ε = 47.0 
(glycerol) (Table 3.3), there was a bathochromic shift of 12 and 6 nm in its absorption and 
fluorescence emission spectra, respectively, while the shape of both spectra remained 
essentially invariant (Figure 3.3A). In contrast, when the free dye was solubilized in both 
fluoroalchools TFE and HFIP, both spectra presented a pronounced hypsochromatic shift 
of 10 – 12 nm relatively to the ones obtained in aqueous solution (Table 3.3). 
 
Figure 3.3: (A) Fluorescence excitation (dashed lines, λem=525 nm) and emission spectra (solid 
lines, λexc=480 nm,) for 1μM free HL488 dye in HEPES-KOH (pH 7.4) buffer (red) and glycerol 
(blue). (B) Excitation anisotropy and fluorescence excitation spectra (red/left and blue/right 
curves/scales, respectively) of 1μM free HL488 dye in glycerol. The solid red line represents the 
experimental anisotropy data after a smoothing operation. Inset: Illustration of the putative 
electronic absorption dipole moments for the S1S0 and S2S0 transitions in HL488 dye (red and 
blue vectors, respectively). The chemical structure of Alexa Fluor 488 was used as a reference 
(Rusinova et al. 2002; Schröder et al. 2005) due to its similar structure. 
Specific solvents effects such as hydrogen bonding, acid-base chemistry or charge transfer 
interactions can be produced due to specific chemical properties of both the fluorophore 
and solvent and result in substantial spectral shifts compared to simple polarity effects 
(Lakowicz 2006). Both these alcohols are substituted with fluorine, and exhibit distinct 
effects, more than the ones expected from the decreased solvent polarity (Yamaguchi et al. 
2006). Possibly the HL488 dye can establish specific interactions with both TFE and HFIP, 
due to the high hydrogen-bonding ability of both fluroalcohols (Sekhar & Udgaonkar 2011; 
Natalello et al. 2011). 
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Table 3.3: Spectroscopic properties of HL488 free dye and HL488-labelled calcitonins in different 
solvents. Maximum absorption, excitation and emission wavelengths ( 𝐚𝐛𝐬
𝐦𝐚𝐱,  𝐞𝐱𝐜
𝐦𝐚𝐱 and 𝐞𝐦
𝐦𝐚𝐱, 
respectively) and steady-state fluorescence anisotropy, <r> S1 (𝐞𝐱𝐜=480 nm; 𝐞𝐦=525 nm). The 
anisotropy values are presented as mean ± standard deviation for a set of ten measurements. The 
concentrations used were 0.8 μM and 1 μM for the free dye and HL488-labelled peptides, 
respectively.       
 
1 20 mM HEPES-KOH, 0.1 mM EDTA, pH 7.4 
2 20 mM HEPES-KOH, 0.1 mM EDTA, 150 mM NaCl, pH 7.4 
3 20 mM HEPES-KOH, 0.1 mM EDTA, pH 7.4 + 100mM DTT 
4 not determined 
Sample Solvent  
𝜆 
𝑎𝑏𝑠
𝑚𝑎𝑥
 
(nm) 
𝜆 
𝑒𝑥𝑐
𝑚𝑎𝑥
 
(nm) 
𝜆 
𝑒𝑚
𝑚𝑎𝑥
 
(nm) 
<r>S1 
HL488 
Buffer 1  500 500 523 0.014 ± 0.013 
+ NaCl 2  500 500 523 0.017 ± 0.013 
Methanol  502 503 523 0.026 ± 0.006 
Ethanol  505 505 526 0.026 ± 0.004 
Propanol  504 504 524 0.088 ± 0.008 
Butanol  506 507 523 0.099 ± 0.011 
Glycerol  512 513 529 0.362 ± 0.005 
HFIP  488 489 505 0.036 ± 0.010 
TFE  490 493 513 0.045 ± 0.015 
sCT-HL488 
Buffer 1  504 504 527 0.069 ± 0.009 
+ NaCl 2  505 504 527 0.066 ±0.009 
DTT3  504 504 527 0.080 ± 0.005 
Methanol  504 505 527 0.048 ± 0.005 
Ethanol  508 507 528 0.232 ± 0.023 
Propanol  508 506 527 0.115 ± 0.007 
Butanol  n.d. 4 509 528 0.228 ± 0.015 
HFIP  489 489 506 0.083 ± 0.007 
TFE  493 493 515 0.088 ± 0.004 
hCT-HL488 
Buffer 1  504 503 529 0.079 ± 0.003 
+ NaCl 2  504 505 528 0.081 ± 0.005 
DTT3  504 504 528 0.080 ± 0.005 
Methanol  504 504 528 0.046 ± 0.003 
Ethanol  506 506 529 0.095 ± 0.005 
Propanol  508 507 527 0.196 ± 0.003 
Butanol  509 510 528 0.231 ± 0.011 
HFIP  488 491 512 0.083 ± 0.007 
TFE  492 492 516 0.081 ± 0.011 
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Fluorescence emission decay kinetics 
The fluorescence intensity decays measured for free HL488 dye in several solvents were 
well described by a mono exponential function, presenting a lifetime of ~ 3.9 – 4.0 ns in 
HEPES-KOH, pH 7.4 buffer (Figure 3.4A and Table 3.4), which is close to the one described 
by the manufacturer (τ=4.1ns) and reported in the literature (τ=4.10±0.15 ns (Schauerte 
et al. 2010). The only exception was the solvent glycerol since a complex three exponential 
function was now necessary to describe the kinetics of free HL488 fluorescence emission 
in this solvent (Figure 3.4A). 
 
Figure 3.4: (A) Fluorescence intensity and (B) anisotropy decays for the free HL488 dye in HEPES-
KOH (pH 7.4) buffer (green) and glycerol (red) (λexc= 335 nm; λem= 525 nm). The high viscosity of 
glycerol at RT greatly reduces the rotational diffusion of the probe resulting in a slow 
depolarization of its fluorescence emission. 
Glycerol characteristically presents a high viscosity at RT and therefore the previous result 
could be due to a slower relaxation rate of the solvent molecules around the excited state 
of this fluorophore. In order to study the dynamics of solvent relaxation, time-resolved 
emission spectra (TRES) were calculated for the free HL488 dye in glycerol accordingly to 
the method described in chapter II (section 2.5.2). The fluorescence intensity decay 
parameters obtained for 0.8μM HL488 free dye in glycerol at different emission 
wavelengths are presented in Table 3.5. 
 
 
A 
B 
Lo
g
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Table 3.4: Fluorescence intensity decay parameters obtained for 0.8 μM HL488 free dye and 1 μM 
HL488-labelled calcitonins in different solvents. The pre-exponential factors obtained for each 
lifetime component, τi, were normalized so that ∑αi=1. <τ>1 and <τ>2 are the amplitude-weighted 
and intensity-weighted mean fluorescence lifetimes (Equation 2.12 and 2.13), respectively. The 
decays were performed using 𝐞𝐱𝐜=335 nm and 𝐞𝐦=525 nm. 
1 20 mM HEPES-KOH, 0.1 mM EDTA, pH 7.4 
2 20 mM HEPES-KOH, 0.1 mM EDTA, 150 mM NaCl, pH 7.4 
3 20 mM HEPES-KOH, 0.1 mM EDTA, pH 7.4 + 100mM DTT 
 
Sample Solvents 
α1 
 
τ1 
(ns) 
α2 
 
τ2 
(ns) 
α3 
 
τ3 
(ns) 
 
<τ>1 
(ns) 
<τ>2 
(ns) 
 
χ2 
 
HL488 
Buffer 1     1.00 3.94  3.94 3.94  1.14 
+ NaCl 2     1.00 3.93  3.93 3.93  1.08 
Methanol     1.00 4.06  4.06 4.06  1.12 
Ethanol     1.00 3.88  3.88 3.88  0.98 
Propanol     1.00 3.75  3.75 3.75  1.14 
Butanol     1.00 4.39  4.39 4.39  1.16 
Glycerol 0.11 0.77 0.22 1.49 0.66 3.52  2.75 3.49  1.01 
HFIP     1.00 4.01  4.01 4.01  1.07 
TFE     1.00 4.01  4.01 4.01  1.06 
sCT-HL488 
Buffer 1 0.13 0.09 0.10 1.38 0.77 3.95  3.19 3.83  0.91 
+ NaCl 2 0.09 0.26 0.10 1.98 0.80 4.01  3.44 3.86  1.02 
+ DTT 3 0.05 0.28 0.05 1.54 0.89 3.95  3.62 3.89  1.04 
Methanol     1.00 4.17  4.17 4.17  1.02 
Ethanol 0.07 0.29   0.93 3.98  3.71 3.91  1.02 
Propanol 0.22 0.23 0.32 2.18 0.46 4.26  2.71 3.64  1.29 
Butanol 0.21 0.13 0.15 2.02 0.64 3.89  2.83 3.65  1.13 
HFIP     1.00 4.63  4.63 4.62  1.13 
TFE     1.00 4.45  4.45 4.45  1.11 
hCT-HL488 
Buffer 1 0.13 0.25 0.18 1.86 0.70 3.96  3.13 3.70  1.05 
+NaCl 2 0.13 0.31 0.19 1.98 0.68 4.00  3.12 3.70  1.07 
+ DTT 3 0.14 0.25 0.14 1.48 0.72 3.74  2.94 3.54  1.06 
Methanol     1.00 4.26  4.26 4.26  1.10 
Ethanol 0.07 0.29   0.93 3.98  3.71 3.96  1.09 
Propanol 0.07 0.90   0.93 3.94  3.73 3.89  1.07 
Butanol 0.15 0.27 0.60 3.24 0.26 4.79  3.23 3.80  0.98 
HFIP     1.00 4.65  4.65 4.65  1.11 
TFE     1.00 4.58  4.58 4.58  1.04 
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As expected, the amplitude-weighted mean fluorescence lifetime obtained for the free dye 
progressively increased from <τ>1~ 1.6 ns at λem=500 nm to <τ>1 ~ 3.9 ns at λem  540 
nm. Concomitantly, a negative pre-exponential was required to describe the intensity 
decays for λem  540 nm, i.e. a rise in the intensity was observed at long wavelengths, 
revealing the formation of a new species: the solvent relaxed state of HL488 in glycerol, 
with a characteristic fluorescence time of 3.6 ns (Figure 3.5A and Table 3.5).  
 
 
 
 
 
 
 
Figure 3.5: (A) Fluorescence intensity decays for free HL488 dye in glycerol at RT with 𝐞𝐦=510 nm 
(red), 525 nm (green) and 595 nm (blue), respectively (𝐞𝐱𝐜= 335 nm). At longer wavelengths 
(blue), a rise in fluorescence intensity can be detected at short times reflecting the formation of the 
relaxed excited state. This characteristic result is associated with negative amplitude obtained 
during the analysis of the fluorescence decays obtained using 𝐞𝐦 540 nm (Table 3.5). (B) Time-
Resolved Emission Spectra of HL488 in glycerol at 0.1, 1.0 and 10 ns after the excitation pulse 
calculated from the decay data presented in Table 3.5. 
Figure 3.5B displays the emission spectra calculated for the free dye in glycerol at 0.1, 1.0 
and 10 ns after the excitation of the sample, respectively. There was a clear time-
dependent red shift while the spectral shape remained essentially invariant with time 
reinforcing the conclusion that the complex decay detected in glycerol was due to the slow 
rotational dynamics of the glycerol molecules around the excited state of the fluorophore 
at RT.  If the sample displayed only ground-state heterogeneity, the decays would be 
dependent upon the emission wavelength but no rise in intensity would be observed 
because all the pre-exponential factors would be positive (Berberan-Santos et al. 1991). 
A B 
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Table 3.5: Fluorescence intensity decay parameters obtained for 0.8 μM HL488 free dye in glycerol 
at different emission wavelengths. The pre-exponential factors obtained for each lifetime 
component, τi, were normalized so that ∑αi=1. <τ>1 and <τ>2 are the amplitude-weighted and 
intensity-weighted mean fluorescence lifetimes (equation 2.12 and 2.13, respectively), respectively. 
The decays were performed using 𝐞𝐱𝐜=335 nm. 
λem 
(nm) 
α1 
 
τ1 
(ns) 
α2 
 
τ2 
(ns) 
α3 
 
τ3 
(ns) 
 
<τ>1 
(ns) 
<τ>2 
(ns) 
 
χ2 
 
505 0.42 0.34 0.39 1.97 0.19 4.34  1.73 3.16  1.23 
510 0.34 0.37 0.36 1.84 0.30 3.81  1.92 2.94  1.05 
515 0.31 0.35 0.37 2.01 0.31 3.88  2.08 2.90  1.20 
520 0.20 0.42 0.27 1.82 0.53 3.53  2.45 3.02  1.01 
525 0.13 0.45 0.28 2.09 0.59 3.58  2.76 3.07  1.22 
530 
  
0.19 1.66 0.81 3.48  3.14 3.20  1.02 
540 -0.11 0.14   1.11 3.48  3.84 3.30  1.10 
550 -0.14 0.53   1.14 3.55  3.98 3.49  1.09 
555 -0.13 0.48   1.13 3.59  4.00 3.61  1.05 
570 -0.08 0.54   1.08 3.61  3.86 3.64  1.01 
595 -0.08 0.54   1.08 3.61  3.86 3.65  1.01 
 
Fundamental Anisotropy 
Due to the breakdown of the Titanium-Sapphire laser available in the laboratory, it was 
necessary to use an excitation wavelength of 335 nm instead of the usual 480 nm in both 
types of time-resolved fluorescence measurements performed in this work. This implies 
that the HL488 fluorophore was excited at its S2S0 instead of S1S0 absorption band 
(Figure 3.3). These experimental conditions should bear no influence on its fluorescence 
intensity decay kinetics measured at the magic angle due to the extremely fast internal 
conversion from the S2 to the S1 excited state. This was already confirmed by comparing 
the fluorescence lifetimes of the free dye in homogeneous media with the values reported 
in the literature. However, the fundamental anisotropy of the molecule, 𝑟0, i.e. its 
fluorescence anisotropy value in the absence of any motion, is known to critically depend 
on the choice of the excitation wavelength used to perform the measurements due to the 
photoselection effect. This occurs when the excitation brings the fluorophore to an excited 
state other than the first singlet state from which fluorescence is emitted. It can be shown 
that for any fluorophore randomly distributed in an homogeneous solution, the value of its 
fundamental anisotropy, 𝑟0, must be within the range from -0.2 (the absorption and 
emission transition moments are perpendicular) to 0.4 (the absorption and emission 
transition moments are collinear) (Lakowicz 2006).  
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In effect, when the emission transition moment of the fluorophore is displaced by an angle 
θ relative to the transition moment of the absorption, its fundamental anisotropy, r0, can 
be calculated using: 
 𝑟0 =
2
5
(
3𝑐𝑜𝑠2Ѳ −  1
2
) [3.1] 
The dependence of the steady-state fluorescence anisotropy of free HL488 in glycerol with 
its excitation wavelength is displayed in Figure 3.1B. This solvent was chosen due to its 
high viscosity at RT (η=945 mPa S (Table 2.2)), allowing to minimize fluorescence 
depolarization due to Brownian motions. Figure 3.3B shows that the HL488 fluorescence 
anisotropy presents a maximum of approximately 0.37 at excitation wavelengths from 450 
to 650 nm, decreasing to a minimum around -0.18 at 335 nm. As explained above, this 
behavior is due to the presence of two electronic transitions, excitation from the singlet 
ground state, S0, to the S1 and S2 excited states, respectively, whose transition dipole 
moments must be close to perpendicular to each other (inset of Figure 3.3B). 
Steady-state and Time-resolved Fluorescence Anisotropy Properties 
The steady-state fluorescence anisotropy measured for the free HL488 dye in its S1 
absorption band is rather low in the majority of the solvents used (Table 3.6), as expected 
for a small fluorophore. Only in the more viscous solvents, a progressive increase in its 
value was observed due to the slower rotational depolarization of its fluorescence 
emission, reaching <r>S1 = 0.3620.005 in glycerol (Table 3.6 and Figure 3.3B) in 
agreement with the predictions from the Perrin  equation for a rigid hydrated sphere: 
 < 𝑟 > =  
𝑟0
1 + 𝜏 𝜑⁄
 [3.2] 
where: 
 
φ =  
η𝑉
𝑅𝑇
 [3.3] 
The rotational correlation time, φ, depends on the the viscosity of the medium, η , and the 
volume of the hydrated sphere containing the fluorophore, V, at a given temperature, 𝑇. 𝑅 
is the ideal gas constant (R=8.314 J K-1 mol-1). The use of an excitation wavelength of 335 
nm implies that the dynamic range for the time-resolved anisotropy measurements is 
approximately half of the one available when exc=480 nm (Figure 3.3.B). However, 
information about the rotational diffusion of the fluorophores during its excited state 
lifetime can still be retrieved from the anisotropy decays, as it is exemplified in Figure 
3.4B.  
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The fluorescence anisotropy decay for the free dye in HEPES-KOH (pH 7.4) buffer was 
very fast, presenting a fast rotational correlation time of ~ 0.2 ns, in agreement with the 
low molecular weight of HL488 (698.4 g mol-1). The depolarization of HL488 fluorescence 
in the more viscous solvent glycerol was much slower, as expected (=55 ns (Table 3.6)). 
It should be noted that in both cases, r(0)= 1 +2 is approximately -0.14 or -0.15, which 
is very close to the fundamental anisotropy measured for HL488 at this excitation 
wavelength (Figure 3.3B). The small differences in this value are due the ultrafast motions 
that cannot be observed within the time resolution of our instrumental step-up. 
 
Figure 3.6: (A) Variation of the steady-state fluorescence anisotropy, <r>S1 (𝐞𝐱𝐜=480 nm and 
𝐞𝐦=525 nm) measured for the free HL488 dye (blue squares), sCT-HL488 (red circles) and hCT-
HL488 (green triangles) with the inverse of the viscosity of the solvent. (B) Dependence of the 
rotational correlation time of sCT-HL488 (red circles) and hCT-HL488 (green circles) with the 
viscosity of the solvent (closed symbols - 𝝋1 and open symbols - 𝝋 2) (T= 20 C).   
 
3.2.1.2. HL488-Labelled Calcitonin Variants 
Absorption and Steady-State Fluorescence Proprieties  
The covalent conjugation of the HL488 fluorophore to both calcitonin variants resulted in 
a ~4 nm red-shift in both their absorption and fluorescence emission spectra relatively to 
the free dye, a common feature of organic dyes (Figure 3.7A and Table 3.3).The chemical 
conjugation of HL488 to the N-terminus of both calcitonin variants also decreased its 
fluorescence quantum yield from Φ=0.74±0.05 (free dye) to Φ=0.60±0.05 and 
Φ=0.50±0.05 for sCT-HL488 and hCT-HL488 in HEPES-KOH, pH 7.4 buffer, respectively.  
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Otherwise, the environmental effects produced by the different solvents used on the 
absorption properties and photophysics of HL488-labelled peptides were very similar to 
the ones previously described for the free fluorophore in solution: there was a progressive 
red-shift, mainly in their absorption spectra, upon decreasing the dielectric constant of the 
medium from water to butanol, and a blue-shift occurred in their absorption and emission 
spectra when the HL488-labelled peptides were solubilized in HFIP and TFE, as compared 
to the buffer solution (Table 3.3). 
 
Figure 3.7: (A) Fluorescence excitation (dashed lines, 𝐞𝐦=525 nm) and emission spectra (solid 
lines,  𝐞𝐱𝐜=480 nm) for 1μM HL488 (blue) and sCT-HL488 (red) in HEPES-KOH (pH 7.4) buffer. 
(B) The steady-state fluorescence anisotropy, <r> S1 (𝐞𝐱𝐜=480 nm ; 𝐞𝐦=525 nm) is independent 
of sCT-HL488 concentration in aqueous solution within a large concentration range (the smallest 
concentration used in the assay was is 1 nM) <r> S1=0.074  0.03 (n=15) . hCT-HL488 displays the 
same behaviour. 
Fluorescence Emission Decay Kinetics 
In contrast to the well described mono-exponential functions measured for free HL488 in 
HEPES-KOH, pH 7.4 buffer, the fluorescence intensity decays of both sCT-HL488 and hCT-
HL488 were now well described by a sum of three exponential terms. However, the longer 
lifetime component of 3~ 4.0ns was always dominant, contributing with more than 90% 
to the total fluorescence intensity of the sample (Table 3.4 and Figure 3.8).  
The use of a high ionic strength buffer did not affect significantly the emission kinetics of 
either HL488-labelled polypeptide. On the other hand, the reduction of their disulfide 
bond with either 0.1 or 1 mM DTT, a strong reducing agent that forms a stable six-
membered ring with an internal disulfide bond (Cleland 1964), produced opposite effects 
on sCT-HL488 and hCT-HL488.  
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In the first case, the amplitude-weighted mean fluorescence lifetime increased from 
<τ>1= 3.2 to <τ>1=  3.6 ns, mainly due to a change in 𝑓3 from 0.95 to 0.98, while 3 
remained essentially invariant. In contrast, for hCT-HL488, there was a decrease in 3 from 
4.0 to 3.7 ns, which caused <>1 to decrease from 3.1 to 2.9 ns (Table 3.4). In HFIP and 
TFE, both HL488-conjugated calcitonin variants presented a mono-exponential 
fluorescence intensity decay, with a long fluorescence lifetime of τ~ 4.6 ns. On the other 
hand, the increase in the chain length of the aliphatic alcohols used to solubilize the 
conjugated peptides progressively augmented the complexity of their fluorescence decays. 
Table 3.6: Fluorescence anisotropy decay parameters obtained for 0.8 μM HL488 free dye and 1 μM 
HL488-labelled calcitonin variants in several solvents. r(0)= 1 + 2. The decays were obtained 
using 𝐞𝐱𝐜=335 nm and 𝐞𝐦=525 nm. 
1 20 mM HEPES-KOH, 0.1 mM EDTA, pH 7.4 
2 20 mM HEPES-KOH, 0.1 mM EDTA, 150 mM NaCl, pH 7.4 
320 mM HEPES-KOH, 0.1 mM EDTA, pH 7.4 + 100mM DTT 
Sample Solvents 
β1 
 
φ1 
(ns) 
β2 
 
φ2 
(ns) 
r(0) 
 
χ2 
 
HL488 
Buffer 1 -0.14 0.21    1.02 
Glycerol -0.15 55    1.01 
sCT-HL488 
Buffer 1 -0.13 1.28   -0.13 1.26 
+ NaCl 2 -0.080 0.56 -0.066 2.68 -0.15 1.18 
+ DTT 3 -0.13 0.89   -0.13 1.09 
Methanol -0.12 1.31   -0.12 1.09 
Ethanol -0.13 2.63   -0.13 1.27 
Propanol -0.11 8.35   -0.11 1.10 
Butanol -0.13 10.4   -0.13 1.08 
HFIP -0.04 0.75 -0.10 5.50 -0.14 1.06 
TFE -0.07 0.75 -0.08 6.73 -0.15 1.18 
hCT-HL488 
Buffer 1 -0.13 1.57   -0.13 1.05 
+ NaCl 2 -0.12 1.47   -0.12 1.15 
+ DTT 3 -0.13 0.95   -0.13 1.10 
Methanol -0.12 1.37   -0.12 1.10 
Ethanol -0.13 1.51   -0.13 1.20 
Propanol -0.14 5.59   -0.14 1.08 
Butanol -0.14 8.21   -0.14 1.20 
HFIP -0.03 0.57 -0.11 6.03 -0.14 1.11 
TFE -0.04 0.52 -0.11 6.08 -0.15 1.05 
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For instance, only a mono-exponential function was necessary to describe the fluorescence 
intensity decay of sCT-HL488 in methanol, a two-exponential function was used to 
describe the decay in ethanol, and a three-exponential function was required for sCT-
HL488 in propanol and butanol (Table 3.4). The origin of the complex fluorescence decays 
obtained for the conjugated peptides compared to the free dye in solution must result 
from dynamic fluctuations of the calcitonin structure which are sensed by the HL488 dye 
(Vaiana et al. 2009). 
 
Although it is often assumed that fluorophores do not interact with amino acids in the 
proteins that they label, the flexibility of the short saturated carbon chains (linker) allows 
for contact with the side chains of nearby amino acids residues, which can result in 
intramolecular fluorescence quenching (Chen et al. 2010; Doose et al. 2005; Vaiana et al. 
2003). These effects can be rationalized in terms of a photoninduced electron transfer 
(PET) mechanism from an electron donor present in several possible adjacent amino acid 
residues to the covalently-conjugated dye HL488 when they are in close Van der Waals 
contact (Chen et al. 2010; Doose et al. 2005), resulting in a non-radiative dissipation of the 
excited-state energy (Figure 3.9).  
 
Lo
g
 
B 
A 
Figure 3.8: (A) Fluorescence intensity and (B) anisotropy decays for the free HL488 dye (green) 
and sCT-HL488 (red) in HEPES-KOH (pH 7.4) buffer) (𝐞𝐱𝐜= 335 nm; 𝐞𝐦= 525 nm). 
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In fact, it has been shown that the side chains of several amino acids can act as quenchers 
of fluorescent organic dyes such as Alexa Fluor (Chen et al. 2010), being Trp and Tyr 
strong quenchers and His and Met weak quenchers. PET-quenching can occur through 
dynamic or static quenching (Doose et al. 2009) and is able to report the intramolecular 
dynamics or conformational changes undergone by the fluorescently-labeled polypeptide 
chains in solution (Vaiana et al. 2003; Doose et al. 2009). Each of the solvents studied, or 
the reduction of the polypeptide disulphide bond, can induce different 
conformations/dynamic fluctuations on sCT-HL488 and hCT-HL488, depending on the 
type of specific interactions that they are able to make with the HL488 structure and the 
polypeptide chain, indirectly modulating their fluorescence emission decay kinetics. 
Alcohols have been used extensively in aggregation studies as they are able to perturb the 
native state of proteins by weakening hydrophobic interactions (Yamaguchi et al. 2006; 
Sekhar & Udgaonkar 2011). 
 
Figure 3.9: (A) When a fluorophore is excited (1) an electron goes from the ground state to the S1. 
When it returns to the ground-state some energy is released via radiactive process (fluorescence-
green arrow). (B) In PET the fluorophore is excited (1) and the electron goes to the first excited 
state (S1). A nearby quencher (Q) donates one of its electrons (2) to the ground state of the 
fluorophore preventing the excited electron to return to ground state (non-radiactive process). 
[Adapted from http://labrigger.com/blog/2012/02/29/tsiens-voltagefluors. Consulted on 
2014/9/25]. 
The effectiveness of an alcohol in its ability to perturb protein structure and stability is 
related to its dielectric constant and viscosity. The reduction of solvent dielectric constant 
enhances charge-charge interactions and diminishes the advantage of sequestering 
hydrophobic components away from solvent (Tanizaki et al. 2008). Fluoroalcohols are 
more effective than ordinary alcohols in disrupting tertiary interactions on folded proteins 
as they lower the solvent polarity by a more drastic extent and favour the formation of 
helical structures by promoting intramolecular hydrogen bonding (Sekhar & Udgaonkar 
2011).  
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Steady-State and Time-Resolved Fluorescence Anisotropy Properties 
The rotational dynamics of both HL488-labeled calcitonin variants was also studied in 
different solvents by performing both steady-state and time-resolved fluorescence 
measurements. Except for the two fluoro alchools used (HFIP and TFE), a single rotational 
correlation lifetime successfully described the anisotropy decays of both these conjugated 
peptides (Table 3.6 and Figure 3.8B). As it is displayed in Figure 3.6B, 1 (and 2 for HFIP 
and TFE) progressively increased with the viscosity of the solvent used as expected from 
the Perrin equation (equation 3.2), clearly demonstrating that this (and not the peptide 
conformation, nor its aggregation state) must be the dominant factor controlling the 
depolarization of the fluorescence from the HL488-labelled peptides in homogenous 
solution. On the other hand, the variation of the steady-state fluorescence anisotropy of 
both sCT-HL488 and hCT-HL488 with 1/ presents two significant outliers for HFIP and 
TFE from the general trend obtained with the other solvents (Figure 3.6A), which must be 
related to the longer mean fluorescence lifetime displayed by these two fluorescent 
polypeptides in both fluoro alchoools. 
For HFIP and TFE, an additional fast rotational correlation time was needed to describe 
the anisotropy decays of both HL488-labelled peptides (1~0.7 ns and 0.5 ns for sCT-
HL488 and hCT-HL488, respectively (Table 3.6)). Since the dye is covalently-attached to 
the protein, one can assume that the depolarization of the fluorescence is now reflecting 
two molecular motions: (i) the local segmental freedom of the dye, which must somehow 
be less restricted in these two solvents, and (ii) the global tumbling of the derivatized 
peptide in solution.  
A common model used to interpret this behaviour is the “wobbling-in-cone” model 
(Poveda et al. 2003; Pastor et al. 2007). Considering that the long rotational correlation 
time (φ2) was significantly longer than the short one (φ1), the total anisotropy can be 
interpreted as the product of two independent processes described above, the first one 
due to fast movements of the peptide segment containing the HL488 dye, 𝑟1(t), and a 
second one related to the global rotational motion of the derivatized peptide, 𝑟2(t): 
 𝑟(𝑡) = 𝑟1(𝑡) · 𝑟2(𝑡) = 𝑟1(𝑡) ∙ exp(− 𝑡 𝜑global⁄ ) [3.4] 
   
 𝑟1(𝑡) = 𝑟(0)[(1 − 𝑆seg
2 ) ∙ exp(− 𝑡 𝜑seg⁄ ) +  𝑆seg
2 ] [3.5] 
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Sseg is the order parameter describing the restricted range of internal angular fluctuations 
of the HL488 dye. Considering that an empirical exponential function given by equation 
3.6 best fitted the experimental anisotropy decay:   
 𝑟(𝑡) = 𝛽1exp (−𝑡/𝜑1)  + 𝛽2exp (−𝑡/𝜑2)  [3.6] 
the fractional anisotropies, βi, and the decay correlation times, φi, can be related with 
equations 3.4 and 3.5 above. The order parameters Sseg can then be written as:  
 
𝑆seg
2 =  
𝛽2
𝛽1 + 𝛽2
 [3.7] 
and the long and short rotational correlation times obtained from the fit are respectively 
related to φglobal and φseg by: 
 𝜑2 = 𝜑𝑔𝑙𝑜𝑏𝑎𝑙  [3.8] 
 
𝜑1 = (
1
𝜑seg
+
1
𝜑global
)
−1
 [3.9] 
Since the fast localized motions derived from the covalently bound dye are restricted, the 
total light depolarization should not be completed, and the anisotropy should not decay to 
zero. Nevertheless, the overall rotation of the peptide is responsible for the anisotropy 
decay to zero at long times (Figure 3.8B). Assuming that the transition dipole moment of 
the dye is moving freely within a cone with a fixed half-angle, θseg, the range of angular 
displacement of these motions can be derived from Sseg (Poveda et al. 2003; Pastor et al. 
2007): 
 
cos 𝜃seg =
1
2
[√(8𝑆seg + 1) − 1] [3.10] 
An angle of θseg ~32 and ~24 were obtained for sCT-HL488 and hCT-HL488 in both 
solvents, respectively (Table 3.7), suggesting that the angular displacements of the dye are 
relatively small when compared to the derivatized peptide as a whole during the 
depolarization process. These constraints on the local motions of the dye are due to the 
short covalent linkage between the dye and the peptide N-terminal. Beyond the probable 
electrostatic interactions with the peptide surface, HL488 is flanked by a disulfide bond 
between amino acid residues 1-7, which must help to limit the local rotational freedom of 
the probe.  
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Table 3.7: Values obtained for the order parameter Sseg and the correspondent half-angle θseg, which 
describes the range of angular motions within a cone available to the HL488 fluorophore covalently 
attached to the two CT variants in homogeneous medium. 
Solvents 
 sCT-HL488  hCT-HL488 
 𝑆seg 𝜃seg  𝑆seg 𝜃seg 
HFIP  0.83 27.8  0.88 23.5 
TFE  0.74 35.6  0.87 24.4 
 
Finally, an important question regarding the behaviour of sCT-Hl488 and hCT-HL488 is 
establishing its aggregation state in aqueous solution. As it is exemplified in Figure 3.7B 
for sCT-HL488, its steady-state fluorescence anisotropy, <r>S1, was found to be 
independent of sCT-HL488 concentration within a large concentration range (1nM ~ 
7.5M): <r> S1=0.0740.03 (n=14). The same behaviour was displayed by hCT-HL488 
with <r> S1=0.0780.04 (n=6). Moreover, it was also found that within the range of 
peptide concentrations used, the steady-state fluorescence anisotropy of sCT-HL488 and 
hCT-HL488 were also independent of the method used in preparing the samples (Method 
A or B, section 2.3.2).  
Finally, if HL488-labelled calcitonin is assumed to behave like a rigid hydrated sphere with 
a partial specific volume, ?̅?, and hydration degree, ℎ, the value obtained for φglobal  can be 
compared with the theoretical prediction from the Perrin equation (Lakowicz 2006):  
 𝜑 =
𝜂𝑀𝑟
𝑅𝑇
(?̅? + ℎ)   [3.11] 
 
Here, 𝑀𝑟 is the relative molecular mass of sCT-HL488 (3 790 Da) and 𝑅 the ideal gas 
constant. Assuming a typically value of ?̅? = 0.73cm3/g for proteins and a hydration of 0.3 g 
H2O/g protein at room temperature (T= 293 K), φglobal is predicted to be 1.4ns for sCT-
HL488 and 1.6ns for hCT-HL488, which is in close agreement to the experimental values 
(φ1 = 1.3ns and 1.6ns for sCT-HL488 and hCT-HL488, respectively (Table 3.6). Altogether, 
these results suggest that both sCT-HL488 and hCT-HL488 behave close to compact 
monomers in HEPES-KOH, pH 7.4 buffer within a large concentration range.  
Curiously, although the disulfide bond present at the N-terminal segment of both 
conjugated polypeptides must help to restrain the local dynamics of the covalently-linked 
fluorophore, this is not an absolute requirement for both sCT-HL488 and hCT-HL488 to 
display a monoexponential anisotropy decay in buffer solution (Table 3.6). 
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In fact, the reduction of the disulfide bond of both HL488-labelled peptides with 1mM DTT 
only slightly reduced their rotational correlation time, implying that this treatment does 
not have a pronounced effect on the polypeptide conformational dynamics in buffer 
solution. 
3.2.2. INTERACTION OF HL488-LABELLED CALCITONIN VARIANTS WITH 
LIPID VESICLES 
The next step of this work was to study the interaction of both HL488-labelled calcitonin 
variants with POPC liposomes prepared with variable anionic phospholipid (POPS) 
content. Since one of the main goals of this investigation was to detect the formation of 
putatively oligomeric intermediates triggered by the interaction of either HL488-labeled 
calcitonin variants with negatively charged lipid membranes, these studies were first 
carried out with relatively high concentrations of the conjugated salmon CT variant, 
namely 1μM and 3.4μM of sCT-HL488.  
3.2.2.1. Influence of sCT-HL488 concentration 
In this first set of experiments, a fixed sCT-HL488 concentration (either 1μM or 3.4μM) 
was added to an increasingly concentration of POPC liposomes containing 20mol% of 
POPS, within the concentration range 0 – 3 mM of total phospholipid. The method used to 
prepare the peptide-containing solutions was method A described in section 2.3.2 above. 
Briefly, the required volume from a concentrated sCT-HL488 stock solution prepared in 
HFIP was directly injected to the liposome suspension in HEPES-KOH buffer, pH 7.4 buffer. 
The final concentration of the solvent was always kept low (<1% vol/vol). Each peptide-
containing sample was prepared independently and UV-Vis absorption, steady-state and 
time-resolved fluorescence measurements were performed to detect and characterize in 
detail the possible intermediate species produced during the interaction of sCT-HL488 
with the anionic lipid membranes within a wide range of peptide/lipid (P/L) molar ratios. 
UV-Vis Absorption Properties 
The absorption spectra of both 1μM and 3.4μM sCT-HL488 revealed a significant red-shift 
with the addition of increasing concentrations of phospholipid, relatively to the spectra 
obtained in aqueous solution, reporting the progressive binding of sCT-HL488 to the 
membrane surface of the negatively-charged lipid vesicles. The maximum absorption 
wavelength of the HL488-fluorescently labeled salmon CT variant changed from 504 nm to 
~508/509 nm for total phospholipid concentrations higher than 2 mM (Figure 3.10A). 
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Simultaneously, there was a change in the shape of the absorption spectra of sCT-HL488, 
particularly at low lipid concentrations. As it is exemplified in Figure 3.10B for 3.4μM sCT-
HL488 in interaction with 0.1 mM POPC:POPS 80:20 LUVs, a “shoulder” appeared in the 
blue region of its absorption spectrum, which was gradually lost upon increasing the lipid 
concentration in solution.  
 
These spectral alterations are characteristic of excitonic interactions between the 
chromophores due to their dimerization (Green et al. 1989; Castro et al. 2012). Additive 
interactions like van der Waals or hydrogen bonding have been suggested to explain the 
forces holding the dye ions together in solution. The self-association between organic dyes 
exhibit distinct changes in the absorption spectrum as compared to the monomeric 
species, and can be used to track the aggregation of the labelled peptides/phospholipids in 
solution/liposomes (Bergström et al. 2002).  
The spectroscopic characteristics in systems with interacting chromophores can be 
explained by the exciton theory, based on a resonance dipole-dipole interaction 
mechanism (Green et al. 1989). According to this, a system of two non-interacting 
monomers splits its excited-state level into two new levels through the interaction of the 
transition dipoles upon dimerization. The interaction energy between the chromophores 
is a function of the transition moment of the monomer.  
 
Figure 3.10: (A) Normalized absorption spectra obtained for 3.4μM sCT-HL488 in interaction with 
increasing concentrations of liposomes: sCT-HL488 in buffer (red), and in the presence of 0.1 mM 
(blue) and 3mM (green) POPC:POPS 80:20 LUVs. (B) Upon increasing the total phospholipid 
concentration, the maximum absorption wavelength obtained for both 1.0 (blue dots) and 3.4μM 
(red dots) sCT-HL488 gradually red-shifted from 504 nm to ~508 – 509 nm. 
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Changes in the absorption spectrum depend on the geometry of the dimer: (a) for parallel 
dimers (H-type) the spectrum consists of a single band blue-shifted with respect to the 
monomer, (b) for head-to-tail dimers (J-type) the spectrum shows a single band red-
shifted with respect to the monomer, and (c) in dimers having intermediate geometries a 
band splitting is observed and the absorption spectrum shows two bands of similar 
bandwidth. 
 
Figure 3.11: (A) When two dipoles are brought to close proximity side by side the energy of the 
individual molecules, E, will split into two new states with the energies E'' and E': parallel dipoles 
repel each other and get the higher energy state, while the antiparallel dipoles attract each other, 
which lowers the energy of that state. Parallel dipoles make up an overall higher dipole moment, i.e. 
stronger absorption, while antiparallel dipoles cancel each other to make a weak absorption. The 
net result is a blue shift of absorption. Similarly for head-to-tail arrangement, the lower energy 
state has a larger transition dipole moment and the net effect is a red shift of absorption. The 
intermediate, oblique, orientation results in band split - two bands appearing at lower and higher 
energy. (B) Illustrative representation of the theoretical prediction for the impact of progressive H-
type dimer formation on the absorption spectra of the chromophore upon increasing its 
concentration in solution. Inset: The normalized absorption spectra of the monomeric and dimeric 
species (H-type dimer) are depicted by closed and open symbols, respectively. [Adapted 
from(Kasha et al. 1965)]. 
A 
B 
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This behaviour is related with the forbidden transitions for each excited state as described 
in more detail in Figure 3.11. Accordingly, the spectral alterations detected in the 
absorption spectra of sCT-HL488 at a high P/L molar ratio (low phospholipid 
concentration) reveal the formation of parallel dimers (H-type) between the HL488 
chromophores covalently linked to sCT. 
As expected, the intensity of the excitonic band was greater for the 3.4μM than for the 
1.0μM sCT-HL488 partition study. This result indicates that upon reaching a high local 
concentration, the fluorescently-labeled peptides must be aligned in parallel on the 
membrane surface, in order for the chromophores to be able to interact with each other. 
Upon increasing the liposome concentration in solution, the surface concentration of 
membrane-bound peptides becomes progressively diluted, effectively preventing their 
dimerization (Figure 3.12). 
Steady-State and Time-Resolved Fluorescence Properties 
Concomitantly, the changes undergone by the fluorescence emission properties of both 1.0 
and 3.4M sCT-HL488 upon interacting with POPC:POPS 80:20 liposomes were also 
characterized. As it is shown in Fig. 3.13A , the intensity-weighted emission wavelength, 
<>, of both concentrations of sCT-HL488 progressively red-shifted from 540.6 – 541.1 
nm to 544.3 nm, upon increasing the total phospholipid concentration in solution, while 
their fluorescence emission spectra remained essentially invariant (data not shown).  
 
Figure 3.12: Influence of the peptide/lipid molar ratio on oligomer formation and fibrillation rates, 
as proposed by Wong et al. Upon increasing the phospholipid concentration the surface 
concentration of membrane bound-peptide becomes more diluted preventing oligomerization on 
the membrane surface[Adapted from (Wong et al. 2009)]. 
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Simultaneously, the integrated areas calculated for the emission spectra obtained for both 
concentrations of fluorescently-labeled sCT, normalized to its initial value in aqueous 
solution, presented a biphasic behaviour (Figure 3.13B). For 1.0 and 3.4M sCT-HL488, 
this parameter sharply decreased to a minimum value of ~80 and ~60% of its initial value 
in buffer solution , respectively, when low concentrations of phospholipid were added to 
the solution (~ 0.1 and 0.2 mM total phospholipid, respectively). Upon further increase of 
the phospholipid concentration, there was a progressive recovery of the integrated 
emission areas which, however, did not reach its initial value when 3.4M sCT-HL488 was 
used (Figure 3.13B).  
The fluorescence emission decay kinetics of both 1.0 and 3.4M sCT-HL488 in the 
presence of increasing concentrations of POPC:POPS 80:20 liposomes were always well 
described by a tri-exponential function. Typically, the short, intermediate and long 
lifetimes increased from 1~0.2 – 0.3ns to ~0.5ns, 2~1.5ns to ~2.0ns and 3~4.0ns to 4.2 
ns, respectively, upon sCT-HL488 binding to the liposomes (Figure 3.13F). The longest 
lifetime, 3, was always the dominant component of the fluorescence intensity decay, 
contributing ca. 90% to the fluorescence emission from the conjugated peptide. 
At variance with the changes displayed by the steady-state fluorescence intensity of sCT-
HL488 (Figure 3.13B), the amplitude-weighted mean lifetime, <>1, for both 
concentrations of sCT-HL488 was almost independent of the phospholipid concentration 
used in the assay (Figure 3.13D), slightly increasing from ca. 3.3 ns in buffer solution to 
~3.7 ns upon binding to the negatively-charged lipid vesicles. In the presence of low 
phospholipid concentrations, <>1 marginally decreased from ca. 3.3 ns to ~3.0 ns 
(Figure 3.13D). 
Altogether, the steady-state and time-resolved fluorescence data described so far for sCT-
HL488 indicate that the HL488-fluorescently labeled peptide undergoes static 
fluorescence quenching in the samples prepared with a high P/L ratio. Since the presence 
of an excitonic band in the absorption spectra of the conjugated peptide is also more easily 
detected under the same experimental conditions, our results provide evidence for the 
formation of non-fluorescent dimers (dark states) when sCT-HL488 reaches a high 
membrane surface concentration at a high P/L molar ratio.  Moreover, control 
experiments revealed that either concentration of the conjugated peptide was not able to 
induce the aggregation of the liposomes used because the light scattered by the liposomes 
showed an identical linear profile with the increasing lipid concentration, in the absence 
and in the presence of the conjugated peptide (data not shown). 
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Figure 3.13: Changes in the steady-state and time-resolved fluorescence emission properties of sCT-
HL488 upon interaction with POPC:POPS 80:20 LUVs. Variation of the (A) intensity-averaged 
emission wavelength, <λ>, (B) integrated emission area, normalized to its value in aqueous solution, 
(C) steady-state fluorescence anisotropy, <r>S1, and (D) amplitude-weighted mean fluorescence 
lifetime, <τ>1, of 1.0 (blue circles) and 3.4μM (red circles) sCT-HL488 with the total phospholipid 
concentration in solution. The solid curves in C are the best fit of equation 2.5 to the data (see the text 
for more details). (E) Normalized amplitudes, αi, associated with (F) each lifetime component, τi, 
obtained from the analysis of fluorescence emission decay kinetics of 1μM (circles) and 3.4 μM 
(triangles) sCT-HL488 in the presence of increasing total phospholipid concentrations: i= 1 (red 
symbols), i= 2 (blue symbols) and i= 3 (green symbols), respectively. 
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Steady-state and Time-resolved Fluorescence Anisotropy Properties 
Finally, both steady-state and time-resolved fluorescence anisotropy measurements 
confirmed that sCT-HL488 partitions to POPC liposomes containing 20mol% POPS, 
corroborating the conclusions retrieved from the spectral alterations described above. 
Figure 3.13C shows that the steady-state anisotropy of both 1.0 and 3.4M sCT-HL488 
increased hyperbolically from <r>S1~0.067 to ~0.23 and ~0.20, respectively, upon 
increasing the total phospholipid concentration in solution. Upon binding to the anionic 
lipid vesicles, the rotational mobility of the conjugated peptides was much more limited 
(see below) (Figure 3.13A), causing an increase in its steady-state anisotropy since the 
intensity-weighted mean fluorescence lifetime, <>2, of sCT-H488 remained essentially 
invariant. Interestingly, despite the biphasic changes described earlier for the steady-state 
fluorescence intensity (integrated emission area) of sCT-HL488 with the lipid 
concentration, <r>S1 varied monotonically with the phospholipid concentration in 
solution for both peptide concentrations used, further supporting the conclusion about the 
formation of non-fluorescent dimers of sCT-HL488 at high P/L molar ratios.  
Assuming that the only fluorescent molecules in solution are the monomeric conjugated 
peptides, either free in solution or membrane-bound, and that there is no homo-FRET 
between the membrane-bound molecules, the large variation observed for the 
fluorescence anisotropy of sCT-HL488 upon its binding to the lipid membrane allows to 
retrieve its partition coefficient. By performing a non-linear regression fit of equation 2.5 
to the experimental steady-state anisotropy data, a 𝐾p=(3.1 ± 0.2)x10
5 and 
𝑟𝑙 =0.2510.004 and 𝐾p = (2.9 ± 0.3)x10
5 and 𝑟𝑙 = 0.2140.005 were obtained for 1μM 
and 3.4μM sCT-HL488 (Figure 3.13C), respectively, using Q=1.1. As a control, the partition 
of free HL488 towards liposomes prepared with the same composition was also studied. 
The dye did not bind to these lipid membranes since there were no spectral alterations, 
nor changes in its steady-state anisotropy value, upon increasing the total phospholipid 
concentration in solution (data not shown).  
More detailed information about the rotational dynamics of sCT-HL488 upon its binding to 
the anionic liposomes was obtained from the analysis of its fluorescence anisotropy 
decays in the presence of increasing phospholipid concentrations (Figure 3.14A). Two 
correlation times were now used to describe the anisotropy decay curves obtained for 
sCT-HL488 in the presence of liposomes. Moreover, a residual anisotropy value, 𝑟∞, was 
also included in these analyses since the fluorescence anisotropy decays of sCT-HL488 did 
not converge to zero at long times (Figure 3.14A e C). 
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This value reflects a restricted rotational motion of the fluorescently-labeled peptide upon 
binding to the anionic membrane. The depolarization of fluorescence due to rotation of the 
conjugated peptides bound to the liposomes comes now  from the local movement of the 
molecule or a segment of the molecule to which the fluorophore is covalently linked (fast 
local motions), subjected to the restrictions imposed by the lipid arrangement 
(intermediate timescale local motions), combined with the rotation of the vesicle as a 
whole (slow global motion), which is in fact too slow to be significant during the time 
window defined by the excited-state lifetime of sCT-HL488 (Figure 3.15) (Zanin et al. 
2013). 
Figure 3.14: (A) Fluorescence anisotropy decays obtained from 1μM sCT-HL488 free in solution and 
in the presence of POPC:POPS 80:20 LUVs (𝐞𝐱𝐜= 335 nm; 𝐞𝐦= 525 nm). The red, blue and green 
solid lines are the best fitting curves of equation 2.14 to the anisotropy decays obtained for sCT-
HL488 in the presence of 0, 0.75mM and 3mM POPC:POPS 80:20 LUVs, respectively. The residuals 
of each fit are also shown below. (B) Illustration of sCT-HL488 binding to the anionic lipid vesicles 
which leads to the restricted rotational motion of the conjugated peptide (not drawn to scale). (C) 
The residual anisotropy value, r∞, obtained for both 1μM (blue dots) and 3.4μM (red dots) sCT-
HL488 progressively decreased upon increasing phospholipid concentration, as expected. The solid 
curves in C are the best fit of equation 2.5 to the data (see the text for more details). 
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Table 3.8: Fluorescence anisotropy decay parameters obtained for 1μM sCT-HL488 in the presence 
of increasing concentrations of phospholipid (POPC:POPS 80:20 LUVs). The decays were obatined 
using 𝐞𝐱𝐜=335 nm and 𝐞𝐦=525 nm and r(0)= 1 + 2 +r. 
Following the model previously used on the interpretation of the fluorescence anisotropy 
decays obtained for sCT-HL488 free in solution, the total anisotropy of the conjugated 
peptide was described by a product of two independent depolarization processes, since 
the two rotational correlations times obtained for the membrane-bound sCT-HL488 
differed by more than an order of magnitude (Table 3.8). In this case, the partition of the 
peptide to the membrane leads to a restriction in its motion, so it can no longer rotate 
freely in solution, and this new situation can be described as a “cone-in-a-cone model” 
(Schröder et al. 2005) or “woobling-in-two-cones” (Melo et al. 2014). The first cone 
describes the local probe motion covalently attached to the peptide (φseg), and the second 
one the restricted motion of the peptide in the membrane (φads) (Figure 3.14B). 
Accordingly, the anisotropy decay can be described as:    
𝑟(𝑡) = 𝑟(0)[(1-𝑆seg
2 ) ∙ exp(− 𝑡 𝜑seg⁄ ) + 𝑆seg
2 ][(1-𝑆ads
2 ) ∙ exp(− 𝑡 𝜑ads⁄ ) + 𝑆ads
2 ] [3.12] 
where 𝑆segand 𝑆ads are the order parameters characterizing the internal and the whole 
fluctuations of the membrane-bound HL488-labeled sCT. Since φads >> φseg the above 
expression can be simplified to the sum of two exponentials functions and a constant term: 
𝑟(𝑡) = 𝑟(0)(1 − 𝑆seg
2 ) ∙ exp(− 𝑡 𝜑seg⁄ ) + 𝑟(0)(1 − 𝑆ads
2 )𝑆seg
2 ∙ exp(− 𝑡 𝜑ads⁄ ) +  𝑟(0)𝑆seg
2 𝑆ads
2  [3.13] 
By directly comparing this new equation to the two exponential function used to 
empirically describe the fluorescence anisotropy decays:  
𝑟(𝑡) = 𝛽1 exp(− 𝑡 𝜑1⁄ ) + 𝛽2 exp(− 𝑡 𝜑2⁄ ) + 𝑟∞ [3.14] 
[LUVs]  
(mM) 
β1 
 
φ1 
(ns) 
β2 
 
φ2 
(ns) 
r∞ 
r(0) 
 
χ2 
 
0.0 -0.13 1.42   0.00 -0.14 1.16 
0.2 -0.06 0.89 -0.05 3.9 -0.02 -0.13 1.10 
0.4 -0.04 0.54 -0.06 3.9 -0.03 -0.14 1.14 
0.75 -0.04 0.74 -0.05 5.1 -0.05 -0.13 0.99 
2.0 -0.03 1.10 -0.04 10.7 -0.06 -0.13 1.08 
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the 𝑆segand 𝑆ads parameters can be written as: 
 
𝑆seg
2 =  
𝛽2 +  𝑟∞
𝑟(0)
 [3.15] 
 
 𝑆ads
2 =  
 𝑟∞
𝛽2 + 𝑟∞
 [3.16] 
By performing a non-linear regression fit of equation 2.5 to the experimental r data 
(considering 𝑟∞
𝑤 = 0), a 𝐾p= (2.2 ± 0.3)x10
5 and 𝑟∞
𝑙 = −0.070  0.003 and 𝐾p=(1.1 ±
0.3)x105 and 𝑟∞
𝑙 = - 0.058  0.007 were obtained for the partition studies carried out with 
1.0 and 3.4M sCT-HL488, respectively, in agreement with the values previously 
calculated with the steady-state anisotropy values. 𝑟∞
𝑙  is the limiting value that would be 
obtained for the residual anisotropy when 100% of the fluorescently-labelled peptide is 
bound to the lipid membranes. 
 
Figure 3.15: (A) Schematic representation of the global peptide rotation (large sphere) and spatially 
confined local dynamics of the probe (small sphere) covalently bound to the calcitonin peptide free 
in solution. (B) Schematic representation of the fast (probe covalently bound to the peptide – the 
smallest sphere) and intermediate (peptide bound to the membrane – intermediate sphere) 
motions which can be analysed according to the wobbling-in-cone model. Slow global motions 
(anionic lipid vesicles – the largest sphere) could not be measured in the experiments of 
fluorescence anisotropy decay because typical rotation times are in the domain of microseconds. A 
and B are not drawn to scale [Adapted from (Ellis et al. 2009)] 
It was then possible to calculate the angles θads and θseg using equation 3.10 as previously 
described, after calculating the respective S  parameters accordingly to equations 3.15 and 
3.16 above. An angle of θseg = 18.1O and θads = 31.1O and θseg = 19.7O and θads = 35.2O were 
obtained for the partition studies performed with 1μM and 3.4μM sCT-HL488, respectively 
(Table 3.9) using the limiting anisotropy value where 100% of the fluorescently-labelled is 
membrane-bound. These results indicate that the amplitude of the local segmental 
motions of the fluorophore covalently linked to the sCT variant became to some extent 
more pronounced upon its binding to the anionic lipid vesicles.  
A B 
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Table 3.9: Partition coefficients, Kp, limiting anisotropy, rl , order parameters Sseg and Sads, and the 
correspondent half-angles θseg and θads obtained for sCT-HL488 in interaction with POPC:POPS 
80:20 LUVs  from the analysis of the steady-state and time-resolved fluorescence anisotropy data.  
𝒓∞
𝒍  is the limiting value that would be obtained when 100% of the fluorescently-labelled peptide is 
membrane-bound. Q=1.1 in all calculations. 
 
In summary, the changes undergone by the spectroscopic properties of 1.0 and 3.4M sCT-
HL488 upon the addition of POPC lipid vesicles containing 20mol% of POPS can be 
described by two coupled equilibria, as illustrated in Figure 3.16. At low total phospholipid 
concentrations (high P/L molar ratio), the majority of the HL488-labeled sCT is free in 
solution; however, due to the low number of liposomes in each sample, the membrane 
surface is very crowded with membrane-bound sCT-HL488, promoting peptide-peptide 
interactions (Wong et al. 2009; Melo et al. 2013) (Figure 3.12). This drives the 
establishment of excitonic interactions between the N-terminally covalently linked 
chromophores and formation of non-fluorescent sCT-HL488 oligomers (possible dimers) 
on the anionic lipid vesicles.  
 
Figure 3.16: sCT-HL488 interaction with POPCPOPS 80:20 LUVs can be described according to a 
two-coupled equilibria model: briefly, monomeric sCT-HL488 is distributed between the aqueous 
solution and anionic membrane phases according to a simple partitioning equilibrium, where Kp is 
the mole fraction partition coefficient defined previously. Upon reaching a high peptide 
concentration on the membrane surface, sCTHL488 assembles into membrane-bound non-
fluorescent oligomers (dark complexes), described by a surface aggregation constant, Kag. 
[sCT-HL488] 
( μM) 
 
Steady-state 
measurements 
 
Time-resolved  
measurements 
 
𝐾𝑝 
( x105) 
𝑟𝑙  
𝐾𝑝 
( x105) 
𝑟∞
𝑙  Sseg 𝜃𝑠𝑒𝑔 Sads 𝜃𝑎𝑑𝑠  
1.0   3.1±0.2 0.251±0.004  2.2±0.3 -0.07±0.003 0.92 18.1O 0.79 31.1O 
3.4   2.9±0.2 0.214±0.005  1.1±0.3 -0.058±0.007 0.91 19.7O 0.74 35.2O 
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According to this model, and as expected, the use of a higher concentration of sCT-HL488 
(3.4μM compared to 1μM) produced a larger static quenching effect, since the 
oligomerization process of sCT-HL488 is concentration-dependent. Upon progressively 
raising the lipid concentration (decreasing the P/L molar ratio), most of sCT-HL488 
becomes membrane-bound but very surface-diluted among the lipid vesicles, which 
effectively prevents peptide-peptide interactions and the subsequent membrane-driven 
peptide oligomerization. The membrane-bound monomeric HL488-labeled sCT is no 
longer undergoing static quenching, and therefore the steady-state fluorescence intensity 
of the samples almost recovers its initial value measured for 1.0M sCT-HL488 free in 
buffer solution.  
3.2.2.2. Influence of lipid composition 
After establishing the importance of sCT-HL488 concentration on its interaction with 
anionic lipid vesicles, we next sought to characterize the influence of the anionic lipid 
content of the liposomes on the partition coefficient of the fluorescently-labeled CT 
variant. According to the interaction model presented above, a lower concentration of 
HL488-labeled peptide was now used in order to shift the coupled equilibria of the system 
towards the membrane-bound monomeric sCT-HL488 species. Following the same 
experimental design used earlier, 0.2M of sCT-HL488 was independently added to 0-
4mM POPC liposomes containing 0, 10, 20 or 30mol% of POPS. 
There was no spectroscopic evidence for sCT-HL488 binding to 100%mol POPC LUVs. 
Both its absorption (Figure 3.17A) and fluorescence emission spectra (Figure 3.17C), in 
addition to its steady-state fluorescence anisotropy (Figure 3.17B), were found to be 
independent of the total phospholipid concentration added to the solution.  
For POPC LUVs containing 10, 20 and 30mol% POPS, a progressive red-shift in the 
maximum absorption wavelength of each sample was detected upon increasing the 
phospholipid concentration, as described earlier (Figure 3.17A), providing evidence for 
sCTHL488 partition to the lipid membranes. Furthermore, no alterations characteristic of 
excitonic interactions were no longer detected in the absorption spectra due to the lower 
concentration of the conjugated peptide used in these experiments, as expected (data not 
shown). The spectral shifts were more pronounced and required a lower concentration of 
total phospholipid to occur as the anionic phospholipid content of the liposomes increased 
from 10 to 30mol%, as it is exemplified in Figure 3.17A for max
Abs .  
Results and Discussion 
95 
 
Surprisingly, in the presence of increasing concentrations of phospholipid up to ~ 2 – 3 
mM, the integrated emission areas of 0.2M sCT-HL488 progressively decreased to nearly 
20% of its initial value measured in aqueous solution (Figure 3.17C), contrasting with the 
previously results. For POPC liposomes containing 30mol% POPS, this parameter almost 
recovered its initial value upon further increasing the phospholipid concentration used in 
the assay (Figure 3.17C – orange triangles). In addition, it should be noted that the 
integrated areas presented a more erratic behaviour than the one obtained earlier with 
1.0 and 3.4M sCT-HL488, which might be related to the lower concentration of peptide 
used in these experiments and/or with the incubation time of each sample before the 
measurements (see below).  
 
Figure 3.17: Variation of the (A) maximum absorption wavelength, (B) steady-state fluorescence 
anisotropy, <r>S1 and (C) integrated emission area, normalized to its value in aqueous solution, 
with the total phospholipid concentration when 0.2μM sCT-HL488 was added to POPC LUVs 
constaining 0mol% (blue circles), 10 mol% (red squares), 20mol% (green diamonds) and 30mol% 
of POPS (orange triangles). The solid lines in (B) are the best fit of equation 2.5 to the initial 
anisotropy data (see the text for more details). (D) Dependence of the apparent or approximate 
sCT-HL488 mole fraction partition coefficient with the mol% of POPS included in the POPC LUVs.  
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Concomitantly, the steady-state fluorescence anisotropy of sCT-HL488 gradually increased 
from <r>S1~0.07 to <r>S1~0.15 with the total phospholipid concentration when 10mol% 
POPS-containing POPC liposomes were employed (Figure 3.17C – red squares), confirming 
that this parameter is an extremely sensitive reporter of HL488-labeled sCT binding to the 
lipid vesicles. Interestingly, for liposomes containing 20% and 30%mol POPS (green 
diamonds and orange triangles in Figure 3.17C, respectively), the anisotropy curves after 
reaching <r>S1~0.20 progressively declined to <r>S1~0.15 for total phospholipid 
concentrations higher than approximately 2mM and 0.5mM, respectively. In order to 
obtain an approximate value for the partition coefficients presented by 0.2M sCT-HL488 
as a function of the anionic lipid content of the liposomes, equation 2.5 was again fitted to 
the experimental steady-state anisotropy data obtained up to 1mM total phospholipid, as 
described in the previous section (Table 3.10). The approximate partition coefficients 
obtained for HL488-labelled calcitonin presented an exponential dependence on the molar 
fraction of POPS incorporated in the anionic lipid vesicles, confirming the importance of 
electrostatic interactions in salmon calcitonin binding to the lipid membranes (Melo et al. 
2011), as expected due to its net charge of +3. 
Table 3.10: Dependence of the apparent or approximate mole fraction partition coefficient, 𝑲𝐩
𝐚𝐩𝐩
, 
obtained for 0.2M sCT-HL488 with the mol% of POPS included in the POPC LUVs. The progressive 
decline in the steady-state anisotropy data detected in some cases for phospholipid concentrations 
higher than 0.2 or 1mM was excluded from the fitting equation 2.5 to the experimental steady-state 
anisotropy data (Q=1.1). 
 
 
 
 
 
Altogether, the results obtained in this set of experiments were surprising, particularly the 
biphasic changes presented by the integrated areas and steady-state fluorescence 
anisotropies measured for 0.2M of sCT-HL488 in the presence POPC LUVs containing 20 
and 30 mol% of POPS. Focusing on the steady-state anisotropy data, which is a less 
concentration-dependent parameter than the fluorescence intensity, several hypotheses 
were considered as feasible justifications for the results obtained:  
mol% POPS  
𝐾𝑝 
( x105) 
𝑟𝑙 
10  (0.9 ± 1.3) 0.168 ± 0.01 
20  (3.0 ± 0.4) 0.222 ± 0.01 
30  (7.4 ± 1.5) 0.212 ± 0.01 
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(i) the possibility that light scattering produced by the liposomes at the highest 
phospholipid concentrations used was affecting these measurements was discarded by 
two considerations: First, a constant <r>S1= 0.0650.002 was obtained for sCT-HL488 for 
all POPC concentrations used (Figure 3.17A – blue circles ), and secondly the diameter 
(Table 2.4 in Chapter II), as well as the light scattered by the lipid suspensions, was found 
to be essentially independent of the anionic lipid content of the LUVs. Furthermore, in 
either case there was no evidence for peptide-induced aggregation of the liposomes, 
irrespective of its anionic lipid content, as the light scattered by the liposomes was also 
found to be independent of the presence of 0.2M sCT-HL488 in solution (data not 
shown).  
(ii) the possible occurrence of homo-FRET between the membrane-bound sCT-HL488 
peptides was also ruled out because this effect only becomes important when membrane 
surface crowding occurs, i.e. at high P/L molar ratios (Melo et al. 2014), at variance with 
the experimental data obtained (Figure 3.17B).  
(iii) eventually, the final drop in the steady-state anisotropy might be an indirect effect 
due to a concomitant increase in the intensity-weighted mean lifetime, <>2, of the 
membrane-bound sCT-HL488. However, this hypothesis is not consistent with the parallel 
decrease measured in its integrated emission area; unfortunately, no time-resolved 
measurements were made in this set of experiments which would allow us to rule out this 
hypothesis. 
(iv) finally, it was considered that kinetic effects, eventually related to the method used in 
the preparation of the samples, might be the major factor responsible for these results. In 
fact, in order to obtain a lower concentration of the fluorescently-labeled peptide in each 
sample (0.2μM), the stock I solution of the fluorescently-labeled peptide (sCT-HL488 
dissolved in 200μL of HFIP) was diluted by a factor of eight to obtain stock II (still using 
HFIP as solvent), before its direct injection to the aqueous medium. This procedure might 
influence the final conformation/aggregation state of the fluorescently-labeled peptide in 
the aqueous solution and its subsequent interaction with the liposomes. This scenario will 
be explored in the next section. 
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3.2.2.3. Influence of the method used to prepare the peptide 
containing solutions 
To evaluate the potential impact of the change made in the method used to prepare the 
samples, the time evolution of the fluorescence properties of both 0.2 and 1.0M sCT-
HL488 in interaction with variable concentrations of POPC:POPS 80:20 and 70:30 LUVs 
was monitored at RT using a micro plate reader (exemplified in Figure 3.18 for POPC LUVs 
containing 20mol% POPS). The time course of the steady-state fluorescence intensity and 
anisotropy presented a clear dependence on the final concentration of the fluorescently-
labeled peptide used.  
 
 
Figure 3.18: Changes in the steady-state (A and B) fluorescence intensity and (C and D) anisotropy of 
sCT-HL488 in interaction with 0 (green curve), 0.1mM (orange curve), 1.0mM (red curve) and 3mM 
(blue curve) POPC:POPS 80:20 LUVs over time. The sCT-HL488 concentrations used were (A and C) 
0.2M and (B and D) 1.0M sCT-HL488, which were obtained from directly injecting the stock I and 
II solutions of the fluorescently-labeled peptide to the liposome suspensions, respectively. Similar 
data was obtained with POPC:POPS 70:30 LUVs over time. 
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For 1μM sCT-HL488-containing samples, there were no significant variations of the 
fluorescence intensity (Figure 3.18A) and anisotropy (Figure 3.18B) of the conjugated 
peptide with time. In addition, the final steady-state anisotropies of sCT-HL488 measured 
after ~16h of sample incubation at RT increased with the total phospholipid concentration 
added to the solution (Figure 3.21), in agreement with the equilibrium study performed 
earlier (Figure 3.13C). On the other hand, the fluorescence intensity of the 0.2μM sCT-
HL488-containing samples significantly augmented over time, still not reaching a constant 
value even after ~16h  of incubation (Figure 3.18C). The initial drop registered for this 
parameter from the value measured for the fluorescently-labeled peptide in aqueous 
solution became more pronounced upon increasing the total phospholipid concentration 
added to the solution, suggesting that this effect is somehow liposome-mediated. 
Interestingly, only the 3.0mM phospholipid-containing sample changed its steady-state 
fluorescence anisotropy over time, rising from <r>S1~0.13 until reaching the expected 
plateau value of <r>S1~0.21  after incubating the sample for 8h (Figure 3.18D). Overall, 
these results confirmed that there were significant kinetic effects at play on the data 
presented above (Figure 3.17); it seems that the final HFIP/sCT-HL488 ratio affects in 
some way the time necessary for the samples to reach equilibrium fluorescence values. In 
order to gain more information about the complex behavior of this system, the kinetics of 
the interaction of 0.2μM sCT-HL488 with 3mM of either 20 or 30 mol% POPS-containing 
POPC LUVs was also monitored over an incubation time of 6h at RT using time-resolved 
fluorescence measurements (exemplified in Figure 3.19 for POPC LUVs containing 
20mol% POPS). Briefly, the mean fluorescence lifetime of sCT-HL488 was constant over 
time (Figure 3.19A) but its value was much lower than the usual (<>1 ~(2.4 ± 0.1)ns 
versus <>1 ~3.5 ns obtained earlier). This result was mainly due to a decrease in the 
contribution of the longest lifetime component, τ3, to the fluorescence decay of sCT-HL488, 
from f3~90% to f3~75-80%, showing that the peptide conformation/dynamics was now 
different in the presence of the anionic lipid vesicles. During the same period of time, the 
limiting anisotropy of sCT-HL488 (measured in S2) progressively decreased (Figure 
3.19B), which explains the concomitant increase in its steady-state anisotropy value 
(measured in S1). 
Finally, to overcome the kinetic effects described above a different methodology of sample 
preparation was tried. This involved re-suspending the HL488-labeled polypeptides using 
a liposome suspension after obtaining a peptide film due to complete evaporation of the 
solvent HFIP, as described in 2.3.2 for method B.  
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Control experiments showed that ~90% of the peptide was recovered after evaporation 
and ressuspension in buffer (data not shown) making this method a promising alternative 
to be used in the preparation of the samples. The influence of the three different 
methodologies used in the preparation of the conjugated peptide-containing samples on 
the kinetics of sCT-HL488/liposome interaction was then tested in parallel by employing 
both 20 and 30 mol% POPS-containing POPC LUVs. Briefly, 0.2μM sCT-HL488 samples 
were prepared by using method A, by either direct injection of the stock solution I or II of 
the derivatized peptide in HFIP to the liposome suspension, or by employing Method B, i.e. 
after an evaporation step of the organic solvent. Illustrative kinetic traces obtained for the 
steady-state fluorescence intensity and anisotropy of the samples are presented in Figure 
3.20. 
 
Figure 3.19: Changes in the (A) mean fluorescence lifetime and (B) limiting anisotropy value for 
0.2μM sCT-HL488 in interaction with 3mM POPC:POPS 80:20 LUVs over time, using direct injection 
from the diluted stock - method A. Similar results were obtained for 0.2μM sCT-HL488 in 
interaction with 3mM POPC:POPS 70:30 LUVs over time. 
The results obtained confirmed that the fluorescence signals from the samples presented a 
significant time evolution only when Method A/stock II solution was used (Figure 3.20A 
and B), since after the HFIP evaporation both fluorescence intensity and steady-state 
anisotropy for 0.2μM kinetics proved to be constant over time (Figure 3.20C and D). 
Moreover, it was found that the equilibrium values measured for the steady-state 
anisotropy of sCT-HL488 after an incubation period of approximately 40h varied 
hyperbolically with the total phospholipid concentration (Figure 3.21). By fitting equation 
2.5 to the experimental data by non-linear regression, 𝐾𝑝 = (1.4 ± 0.1) × 10
5 and 𝑟𝑙 =
0.249 ± 0.005 were obtained, which are in agreement with the previously data on Table  
3.9. 
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In conclusion, it was established that the method used to prepare the sCT-HL488-
containing samples critically affects the kinetics of its interaction with POPC liposomes 
prepared with a variable content of POPS, a negatively-charged phospholipid. To 
overcome these effects, the method used to prepare the samples was therefore switched 
to method B.  
 
Figure 3.20: Changes in (A and C) the steady-state fluorescence intensity and (B and D) anisotropy 
of 0.2μM sCT-HL488 in interaction with 0mM (green curve), 0.1mM (orange curve), 1.0mM (red 
curve) and 3mM (blue curve) POPC:POPS 80:20 LUVs over time. (A and B) The samples were 
prepared using method A/stock II (direct injection from the diluted stock solution) or (C and D) 
using method B/stock II (using a HFIP evaporation step). The results obtained using samples 
prepared using method A/stock I were similar to the ones presented for method B/stock II, i.e. both 
the fluorescence intensity and anisotropy of the samples were constant over the incubation time. 
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3.2.2.3. hCT-HL488 Partition 
The partition behaviour of hCT-HL488 towards anionic lipid vesicles was then studied 
using method B in the preparation of samples. As occurred in the intrinsic fluorescence 
study of hCT, described in section 3.1, no changes in the UV-vis absorption spectra or 
emission fluorescence (Figure 3.22A) upon addition of POPC:POPS 70:30 vesicles were 
detected for 1μM hCT-HL488. In addition, its steady-state anisotropy was independent of 
the phospholipid concentration used (< 𝑟 >= 0.079 ± 0.002 (𝑛 = 11)), revealing no 
interaction with the anionic lipid membranes (Figure 3.22B).  
 
In fact, even when POPC:POPS 50:50 LUVs were used in the partition study to force their 
interaction with hCT-HL488, still no alterations on any of the fluorescence parameters 
measured for hCT-HL488 were noticed (𝑒. 𝑔. , < 𝑟 >= 0.084 ± 0.003 (𝑛 = 11 )). Together 
with the results obtained from the intrinsic fluorescence studies (section3.1), our data 
shows that human calcitonin does not interact with POPS-containing vesicles.  
Figure 3.21: Average equilibrium steady-state fluorescence anisotropy values measured for 0.2 μM 
sCT-HL488 in interaction with POPC:POPS 80:20 LUVs after incubating the samples for 40h at T= 
25C. The methods used in preparing the samples were method A/stock I (red squares), method 
A/stock II (green triangles) and method B (blue circles), respectively. The solid line is the best fit of 
equation 2.5 to experimental data obtained suing method B.  
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Figure 3.22: (A) The steady-state anisotropy values and (B) relative steady state fluorescence 
intensities presented a constant value upon increasing the phospholipid concentration using 
POPC:POPS 70:30 (blue circles) or POPC:POPS 50:50 (red squares) showing no interaction/binding 
of 1μM hC-HL488 to the negatively-charged phospholipids. The dashed line represented in A is the 
mean anisotropy value of <r> ~0.081. 
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4. CONCLUDING REMARKS 
In the past few years, accumulated evidence supports the conclusion that lipid membranes 
can catalyse the conversion of several amyloidogenic protein/peptides into toxic 
aggregates (amyloid assemblies) (Zhao et al. 2004; Butterfield & Lashuel 2010; Relini et al. 
2013; Relini et al. 2014). The anionic phospholipid content of the lipid membranes is 
considered to be a major factor controlling the binding of several amyloidogenic 
peptides/proteins to the membrane surface and the subsequent conformational change 
that ultimately leads to amyloid fibril formation (King et al. 1999; Apostolidou et al. 2008; 
Jayasinghe & Langen 2005; Orte et al. 2008; Zhao et al. 2004). However, the detailed 
mechanism(s) involved in this process is (are) not yet fully understood, nor the 
intermediate species formed along these pathways have been completely characterized 
(Zhao et al. 2004; Gorbenko & Kinnunen 2006). The aim of this work was to investigate 
the ability of negatively-charged lipid membranes to induce the formation of amyloid 
assemblies under conditions close to physiological using calcitonin as model polypeptide, 
in order to elucidate the features that govern the formation of peptide-membrane toxic 
species. Hopefully, the understanding of these mechanisms will help unravelling the 
pathways that cause several human diseases like Alzheimer’s and Parkison’s diseases. 
CT is a 32-amino acid peptide hormone with an N-terminal disulphide bridge between Cys 
1 and Cys 7 and a C-terminal proline amidated residue (Figure 2.1). Both the human and 
salmon variants of this peptide hormone were used in this study as the time scale of their 
fibrillogenesis kinetics in solution is quite distinct (Diociaiuti et al. 2011). Previous studies 
have also already revealed prominent contributions of membrane interactions toward CT 
fibrillization (Arvinte & Drake 1993; Stipani et al. 2001; Diociaiuti et al. 2011) and 
indicated the formation of CT-induced oligomeric pores in lipid bilayers (Diociaiuti et al. 
2006). However, most of these studies have been essentially qualitative, and an integrative 
quantitative model describing hCT and sCT interactions with membranes is still missing. 
Two complementary fluorescence approaches were employed in this work when studying 
CT interaction with POPC LUVs containing variable mol% of POPS: the extrinsic 
fluorescence properties of both HL488-labeled CT variants were used for sensing their 
membrane binding/oligoerization  and these results were compared with previously ones 
obtained for the unlabelled CT peptides by exploring their intrinsic fluorescence 
properties due to their Tyr residue (Y22 and Y12 in sCT and hCT, respectively (Figure 
2.1).  
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Although this last methodology is non-invasive, as the auto fluorescence of both 
unmodified CT variants eliminates the possible perturbation introduced by the fluorescent 
label, its application to peptide-membrane partition studies can be compromised by the 
conjugation of two factors, namely the highly scattering properties of the liposome 
suspensions used in these studies and the characteristic low brightness of Tyr residues. 
After establishing a correction procedure for the impact of light-scattering on the steady-
state fluorescence anisotropy measurements used to monitor CT binding to POPC LUVs 
containing 20mol% of POPS, a 𝐾𝑝 = (5.5 ± 0.3)x10
5 was recovered for sCT. Under the 
same experimental conditions, no evidence was found for hCT binding to membranes 
prepared with the same lipid composition. 
In the second part of this work, the extrinsic fluorescence properties of both HL488-
labelled CT variants were used to gain information about the polypeptide dynamics in 
homogeneous solution and their interaction with membranes prepared with variable 
anionic lipid content. As this fluorescent dye has been recently commercialized, a small set 
of solvents was first used to explore the environmental effects on the photophysics of both 
the free HL488 dye and HL488-labelled CTs. This was important to provide an 
interpretation framework for the spectroscopic data obtained later when studying the 
interaction of both HL488-labelled calcitonin variants with liposomes.         
The results obtained in the solvatochromic study performed with a number of alcohols 
with different lengths of aliphatic chain (methanol, ethanol, propanol and butanol) and 
fluoro alchools (TFE and HFIP) do not conform to the general solvent effects. In fact, 
usually absorption spectra are less sensitive to changes in the solvent polarity, but 
fluorescence emission spectra are seen to shift dramatically to longer wavelengths with 
the increasing solvent polarity. This effect is related with the larger dipole moment in the 
excited state that interacts with the polar solvent molecules and reduces the energy of 
excited state (Lakowicz 2006). Our data, however, suggest that specific solvent effects 
such as hydrogen bonding, acid-base chemistry or charge transfer interactions, must be at 
play here due to the progressive bathochromic shift detected in the absorption and 
fluorescence emission spectra of both free dye and the fluorescently-labelled peptides 
upon reducing the dielectric constant of the medium from ε= 80.4 (water) to ε= 47.0 
(glycerol), and a pronounced hypsochromic shift measured when both were solubilized in 
the fluoroalchools (TFE and HFIP). Since the chemical structure of the dye is unknown, it 
is not possible to further speculate on this topic. 
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At contrast with what was observed for the free dye, the fluorescence intensity decays 
measured for sCT-HL488 and hCT-HL488 in homogeneous medium were critically 
influenced by the solvent used. The dynamical fluctuations of the polypeptide chain must 
allow for close contact with nearby amino acids, resulting in a photon induced electron 
transfer (PET) quenching mechanism of HL488 caused by transient nearby residues such 
as tyrosine, methionine and histidine. Therefore, the fluorescence emission kinetics of the 
derivatized peptides reflect their conformational dynamics in the solvent used (Vaiana et 
al. 2009; Doose et al. 2005; Chen et al. 2010).  In fact, over the last years, the effect of 
alcohols on the fibrillation mechanism of polypeptides in solution has been increasingly 
investigated. Changes in the conformational sampling of peptides depending on high, 
intermediate and low dielectric environments of peptides have been reported 
(Munishkina et al. 2003; Tanizaki et al. 2008). Fluoroalchools (HFIP and TFE) have been 
used to mimic the effects of membranes on proteins since these solvents destabilize the 
native states of proteins allowing the formation of partially unstructured forms in the case 
of folded proteins and partially folded forms in the case of unstructured proteins 
(Munishkina et al. 2003; Sekhar & Udgaonkar 2011). In addition, it has been shown that 
high concentrations of HFIP and TFE stabilize the helical content of some peptides (Chen 
& Wetzel 2001; Mukhopadhyay et al. 2006; Natalello et al. 2011) as expected from a 
strengthening of hydrogen-bonding interactions in lower dielectric environments, and 
high concentrations of methanol, ethanol and propanol stabilized the β-structure content 
in proteins. Wang and co-workers have recently shown that HFIP and TFE can induce 
almost 100% of α-helical content on bovine calcitonin, but in aqueous solution (several 
buffer systems were studied) only 20% of α- helical content was identified in this peptide 
(Wang et al. 2005). Furthermore, it has been shown that although sCT and hCT adopt a 
random coil conformation in aqueous solution, they easily acquire an α-helical secondary 
structure in the presence of organic solvents (Arvinte & Drake 1993; Diociaiuti et al. 
2011). 
In the near future we plan to study the conformational equilibria of both sCT and hCT as a 
function of the solvent used with circular dichroism (CD) as a complementary tool. 
Hopefully, we will be able to relate the data obtained in these studies with the complexity 
described for the fluorescence intensity decays obtained here for sCT-HL488 and hCT-
HL488 in each solvent, which will contribute to further elucidate the dynamics of salmon 
and human calcitonins in homogeneous solution. 
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The steady-state and time-resolved fluorescence studies performed with both 
fluorescently-labeled CT variants further provided important information about their 
aggregation state in aqueous solution. The steady-state anisotropy values were found to 
be independent of the sCT-HL488 and hCT-HL488 concentration used (Figure 3.7). 
Together with the prevision from the Perrin equation, it was concluded that both peptides 
behave as compact  monomers in aqueous solution within a wide range of concentrations  
(from ~1nM to ~8μM). 
In the last part of our work, we were able to show that the interaction of sCT-HL488 with 
lipid membranes was dependent on (i) the method used to prepare the samples, (ii) the 
concentration of the fluorescently-labeled peptide used, and (iii) the mol% of POPS 
included on the POPC liposomes. By far, the most intriguing result obtained in this study 
was finding that a 8-fold dilution of the stock solution I of sCT-HL488 in HFIP critically 
affected the kinetics of its interaction with POPC liposomes prepared with a variable 
content of negatively-charged phospholipid. It was shown that upon increasing the 
proportion of HFIP relatively to the fluorescently-labeled peptide in stock solution II prior 
to its direct injection into each sample, the fluorescence measurements took a much longer 
time to reach an equilibrium value. This effect was apparently more pronounced upon 
increasing the total phospholipid concentration of the sample/anionic lipid content of the 
liposomes, suggestion that it was liposome-mediated. It seems that sCT-HL488 interacted 
very fast with the lipid vesicles used in each assay but was initially trapped in a highly 
quenched state, eventually with a distinct conformation/aggregation state, that slowly 
evolved into the usual fluorescent species. To overcome these effects, the method used to 
prepare the samples was therefore changed and the organic solvent was eliminated by 
evaporation prior to sample preparation (method B) (Rolinski et al. 2010; Amaro et al. 
2011). Despite the fact that the problem was solved (i.e. slow interaction kinetics of sCT-
Hl488 with the membranes), we still need to perform further studies to fully understand 
the origin of these effects. 
Regarding the influence of sCT-HL488 concentration on its interaction with POPC:POPS 
80:20 LUVs, the data obtained could be adequately described by a coupled 
partition/oligomerization equilibria. Briefly, using 1 and 3.4μM of sCT-HL488, the UV-Vis 
absorption spectrum was found to progressively red-shifted upon increasing the 
phospholipid concentration (Figure 3.10A), but a shoulder was detected in the blue region 
of their absorption spectra at low lipid concentrations (high P/L molar ratio) (Figure 
3.10B).  
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These findings were explained by the exciton theory where the dipole-dipole interactions 
between interacting fluorophores in parallel geometry (H-type) generate a blue-shifted 
band in the absorption spectrum, showing sCT-HL488 oligomerization upon crowding of 
the membrane surface. Concomitantly, there was a drop in the fluorescence intensity of 
sCT-HL488, which was not accompanied by significant changes in its mean fluorescence 
lifetime. Thus, the peptide-peptide interactions that occurred at a high P/L ratio produced 
non-fluorescent membrane-bound oligomers (Figure 3.16).   
Finally, we were able to show that CT binding to negatively-charged liposomes was 
dominantly driven by electrostatic interactions. The apparent partition coefficient 
obtained for sCT-HL488 increased exponentially with the mol% of POPS included in the 
LUVs, in agreement with its net charge of +3. However, no spectroscopic evidence was 
obtained for either sCT-Hl488 binding to POPC vesicles, nor for hCT-HL488 (with a net 
charge of +1) binding to 30 or 50mol% POPS-containing POPC LUVs. The possible 
interference of the fluorescent label used on the partition behaviour of the modified 
peptides was also ruled out since very similar partition coefficients were obtained for sCT 
and sCT-HL488 in the intrinsic and extrinsic fluorescence studies performed with 
POPC:POPS 80:20 LUVs. The absence of human calcitonin interaction with negatively-
charged vesicles, the opposite of some other mechanisms already described in the 
literature (Stipani et al. 2001; Wagner et al. 2004; Herbig et al. 2005) can arise from 
differences on the membrane compositions,  such as the use of cholesterol-rich and 
ganglioside-containing vesicles, which usually resulted in substantial conformational 
changes and substantial increase in its membrane  binding affinity, as described earlier for 
other peptides (Jayasinghe & Langen 2005; Apostolidou et al. 2008; Knight et al. 2008; 
Fantini & Yahi 2010). 
The intermediate oligomers formed on the fibrillization pathway of several amyloidogenic 
peptides/proteins (Gorbenko & Kinnunen 2006; Diociaiuti et al. 2011), often with a β-
sheet structure (Relini et al. 2004; Chimon et al. 2007; Ono et al. 2009) have been 
identified as the main cytotoxicity species instead of the mature amyloid fibrils per se. The 
performance of additional studies using thioflavin T (ThT) binding (Ryan et al. 2008; 
Biancalana & Koide 2010) and CD measurements will eventually allow the detection of 
potential conformational changes of sCT/hCT to β-sheet rich structures as a function of (i) 
the peptide and phospholipid concentrations used, and (ii) lipid composition of the 
liposomes.
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